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Abstract 
This thesis entitled ‘The Synthesis and Study of Novel Squaramide Scaffolds: 
From Sensors to Soft Materials’ is divided in 6 Chapters. Chapter 1, squaramide 
based receptors as potential anion sensors, gives a brief introduction into the 
history of anion recognition and the significant role anions play in biology and in the 
environment. A range of relevant examples of anion receptors and sensors from the 
literature are also given. This Chapter concludes with the aims of the research 
conducted in Chapter 2. 
In Chapter 2, a set of novel squaramide based anion receptors are 
described. The synthesis of each receptor is discussed in addition to their 
photophysical and anion binding properties.  
Chapter 3, squaramide based low molecular weight gelators (LMWGs), gives 
a concise background into the field of gels, from their formation and classification 
to their characteristics. It also gives a brief introduction on the topic of 
supramolecular gels with some relevant examples from the literature. This Chapter 
concludes with the aims of the research conducted in Chapter 4. 
In Chapter 4, a series of novel squaramides potential low molecular weight 
oragano-gelators (LMWOGs) are described. The synthesis of each new compound is 
discussed, in addition to preliminary gelation tests. 
In Chapter 5, an overall conclusion of the entire preceding chapter is given. 
Finally, in Chapter 6, general experimental procedures are outlined and the 
synthesis and characterisation of each of the compounds is given. Subsequently, 
literature references are provided and are followed by the Appendix which provides 
spectroscopic, titration data and photographic images to support work described in 
the main text. 
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1.1 Introduction 
The recognition of anions is a broad field of supramolecular chemistry.1 Several 
hosts incorporating functional groups such as ureas, pyrroles, indoles, amides and 
sulfonamides have been shown to successfully complex a range of anionic guests 
via hydrogen bonding.2-6 Generally, these receptor molecules are designed with 
some degree of pre-organisation, resulting in a cleft-like structure.7, 8  
The catalytic activity of most organocatalysts involves groups such as those listed 
above via hydrogen bonding to highly anionic or negative intermediate.9-15 The 
major objective of receptor design is the molecular recognition of anions, giving rise 
to the potential application of molecular receptors for anion recognition.16, 17 
This review Chapter will present a review of the areas of anion recognition giving a 
brief history, some key findings and more recent developments. 
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1.2 Why Anions? 
Anions play a crucial role in biology and industrial processes and hence their 
recognition and detection has gained considerable research attention.18-20 For 
example, chloride is essential in biological systems and is involved in a variety 
cellular and physiological function, such as in regulating membrane potentials.21 
Misregulation of chloride concentrations is associated with a number of diseases, 
including cystic fibrosis.22 Cyanide is also a well-recognised anion, for its extremely 
high physiological toxicity and its presence as an environmental pollutant due to 
widespread use in photography, gold mining and petrochemical industry.23 Bromide 
is found in saliva, serum and urine of living organisms.24 Bromide deficiency results 
in hyperthyroidism which inhibits growth, fertility and life expectancy. However, 
excess bromide leads to bromide toxicity “bromism” which results in skin 
eruption.25, 26 Fluoride ions are important for oral care and are present in 
toothpastes.27, 28 Fluoride ions help to maintain healthy bone structure in the 
human body.29 However, excess of fluoride intake results in skeletal fluorosis, a 
disease which causes stiffness, pain and calcification of bones in the body.30 
Phosphate is an essential component of many important biomolecules like ATP 
(energy production), DNA (genetic information), Haemoglobin (oxygen carrier) and 
RNA (protein synthesis).31 Phosphate has crucial role in bone and teeth 
development,32 signal transduction and energy storage in biological systems.33 
Excess use of phosphate and nitrate anions lead to eutrophication of lakes and 
waterways.34 Sulfate is a prominent troublesome species in the nuclear wastes that 
can interfere in their treatment processes.35, 36 Therefore, the development of novel 
receptors for monitoring of these anions in various physiological and environmental 
samples is extremely important and has become an active area of research. As 
outlined above there is a variety of anionic species that carry out diverse functions 
in both biological process and the environment. 
The design of selective and sensitive anion receptors is extremely important but 
also challenging task18. Anions are generally larger than cations and therefore have 
lower charge to radius ratio.37 Under acidic conditions, anions may become 
sensitive to pH and become protonated, thus losing their charge. Solvent effects 
can also play a major role in controlling binding strength and selectivity. Some 
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solvents can form H-bonds to anions and an anion receptor must compete with the 
solvent for the binding site. Anions also possess a wide range geometries, resulting 
in a high degree of pre-organisation being required for effective anion receptor 
design. Halides such as bromide (Br-), chloride (Cl-), fluoride (F-) and iodide (I-) are 
spherical in shape while linear anions include cyanide (CN-) and hydroxide (OH-). 
Nitrate (NO3
2-) and Carbonate (CO3
2-) ions are trigonal planar in nature whereas 
dihydrogen phosphate (H2PO4
3-), phosphate (PO4
3-) and sulfate (SO4
3-) are 
tetrahedral anions. Examples of Y-shaped anions include; acetate (AcO-) and 
benzoate (BzO-) (Figure 1.1). 
Halides
 
Spherical
Cyanide, Hydroxide
Linear
Carbonate, Nitrate
Trigonal planar
Acetate, Benzoate
Y-shaped
Phosphate, Sulfate
Tetrahedral
 
Figure 1.1: Different types of anion shapes showing examples of spherical, linear, 
trigonal planar, tetrahedral and Y-shaped anion.  
Given these variations and the complex nature of anion recognition, a number of 
approaches have been pursued. The following section will outline the development 
of the field of anion recognition and summarise some of the recent advances in the 
area. 
 
1.3 Anion Recognition 
The slow developing field of anion receptor chemistry began in the late 1960s by 
Shriver and Biallas38 and by Park and Simmons.39 However, Park and Simmons 
discovered that deprotonated bicyclic katapinands could encapsulate halide ions as 
a result of hydrogen-bonding interactions (Figure 1.2),39 a finding that heralds the 
field of anion coordination chemistry.40 Until approximately 30 years ago, the 
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coordination of anions was relatively unexplored even with the development of the 
first synthetic receptor by Park and Simmons in 1968.39  
 
Figure 1.2: Katapinate diammonium salts with complexed and free chloride anion.39 
In the mid-1970s, Lehn and co-workers also reported macrotricyclic hosts, which 
could encapsulate halides.41 Coordination of anions has become an important area 
of supramolecular chemistry due to potential applications in the fields of biology, 
the environment and chemical processes.18, 39 Anion coordination chemistry was 
originally concerned with the design and synthesis of simple uncharged receptors 
which could complex anions in an organic environment,42 However, the focus has 
recently shifted towards the selective anion binding in aqueous solvent 
conditions,43 selective sensing of significant biological anions in vivo,44 anion 
transport across cell membranes,21 detection of anionic pollutants at very low 
levels,45 and extraction and transport of specific anions against Hofmeister bias 
from aqueous to organic conditions.46 
 1
Metal-anion complex47 
 Butler
OH
2
 2
Lewis acid receptor38
 Shrivers and Biallas
 
Figure 1.3: Receptor capable of binding anionic guest via metal anion 
complexation47 and an example of a Lewis acid receptor.38 
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Receptors may complex anionic guest through metal-anion complexation47-50 
(Figure 1.3) and strong electrostatic interactions.51 Complexation of receptors to 
anionic guest could also occur via weaker but more directional interactions such as 
𝜋-anion,52 Lewis acid-base,38, 53 hydrophobic effects or hydrogen bonding (H-
bonding),19, 54, 55 the most common being through hydrogen bonding.18, 56 Given the 
subject matter of this thesis the following sections will concentrate on anion 
receptors based on hydrogen bonding interactions. 
Hydrogen bonds are directional, which allows for the possibility of designing 
receptors with specific shapes that are capable of differentiating between anionic 
guests with different geometries or hydrogen-bonding requirements in non-polar 
solvents.37 Several H-bonds can be incorporated into a supramolecular structure to 
form a cleft with convergent H-bonding groups, able to cooperatively bind anions. 
Some neutral anion receptors bearing groups such as pyrrole,3, 57, 58 indole,4, 59 
amide,60 sulphonamide,6 squaramide,61, 62 urea and thiourea4, 63-66 groups as H-bond 
donors have been reported to effectively bind anions (Figure 1.4). 
Pyrrole Indole Amide Sulfonamide Squaramide Urea Thiourea  
Figure 1.4: Some functional groups capable of H-bonding to anions. 
However, secondary amides are generally used in anion receptors as they act as 
efficient H-bond donors.67 Secondary amides can also act as H-bond acceptors 
which promotes intra-molecular H-bonding, self-association and disruption to anion 
binding. However, they have been found to effectively bind anions,68 neutral 
molecules such as dicarboxylic acids69 and barbiturates.70 Pyrrole and indole based 
receptors can only act as H-bond donors, thus intramolecular H-bond formation 
which can inhibit anion binding is not possible (Figure 1.4). Sulfonamide moieties 
have been shown to be effective anion receptors due to their highly acidic H-bond 
donating groups (Figure 1.4).71 Squaramide moieties have also been reported to 
bind halides and oxyanions with high binding strength.61 Ureas and thioureas are 
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commonly known to be efficient anion receptors, due to their possession of two N-
H groups which can bind a single acceptor atom such as a halide anion resulting in 
the formation of a six-membered chelate ring or can also bind two adjacent oxygen 
atoms of an oxyanion resulting in the formation of an eight-membered ring system. 
The most important challenge of anion recognition is to develop synthetic receptors 
for binding of particular anions selectively in highly competitive solvents. The next 
sub-sections will provide a general overview of anion binding including a 
consideration of the design of simple anion receptors and comparison of their anion 
complexation abilities. Due to the large number of examples in the literature, this is 
not intended to be an exhaustive list but a summary of some of the more important 
examples and those pertinent to the subject of this thesis. 
 
1.4 Indole Based Amide/Urea Receptors for Anion Binding 
Indoles and indole-based receptors are a modern feature of anion coordination 
chemistry.56 In 2007, Pfeffer et al. developed indole receptors which also 
incorporated amide, urea and thiourea groups and 1H NMR spectroscopic titrations 
with several anions were conducted, monitoring all four N-H groups of the 
receptors 3-5 (Figure 1.5).4 Deprotonation of the indole N-H and urea N-H groups 
occurred with F- for 3-5. Receptors 3 and 4 were shown to possess strong AcO- 
binding and weaker Cl- and Br- through the urea groups with only minor binding 
observed to the indole and amide N-H groups. However, in the case of the larger 
receptor 5 with AcO-, the amide and indole bound the anion strongly upon the 
addition of 1 equivalent of anion. At which point the large size could accommodate 
independent anion binding at these sites. Ka values of approximately 7,900 M
-1 in 
DMSO-d6 were obtained for 5 with both AcO
- and H2PO4
- lower values were 
obtained for Cl- binding. 
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 4  5 3
Figure 1.5: Structure of Indole based urea and thiourea receptors studied by Pfeffer 
et al. in 2007.4 
Bates et al. developed a series of functionalised indoles with bis-amides attached 
and ureas in a similar cleft arrangement to an isophthalamide and found they 
strongly bound to AcO- in wet DMSO (Figure 1.6).72 The amide functionalised 
indoles bound anions more weakly compared to the urea analogues whereas the 
thiourea derivative gave lower Ka values due to steric effects with the sulfur (S) 
atom inhibiting the approach of anions.  
9: X = O, R = C
4
H
9
, R1 = C
4
H
9
 
10: X = O, R = Ph, R1 = Ph
11: X = S, R = Ph, R1 = Ph
6: R = C
4
H
9
, R1 = C
4
H
9
 
7: R = Ph, R1 = Ph
8: R = PhCH
2
, R1 = Ph  
Figure 1.6: Indole receptors developed by Bates et al. in 2007.72 
Furthermore, after recognising the minor role played by the amide at the 2-position 
in the coordination of anions evaluated in the indole receptors 6-11 (Figure 1.6). 
Caltagirone et al. synthesised 1,3-diindolylurea and 1,3-diindolylthiourea based 
receptors (Figure 1.7).59 The urea receptors showed a high affinity for oxoanions 
and a particular selectivity for H2PO4
- in DMSO-d6 (Ka > 10
4 M-1 in presence of 0.5% 
H2O for oxyanions; 4790 M
-1 in 10% H2O for H2PO4
-). X-ray crystallography showed 
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that the diindolylurea 12 was bound to BzO- through four H-bonds incorporating all 
N-H groups (Figure 1.7). However, due to the steric effects from the large S atom, 
significantly lower Ka values were observed for thioureas. 
(a)                                                                 (b) 
12: R = Me, X = O
13: R = H, X = O
14: R = Me, X = S
15: R = H, X = S              
Figure 1.7 (a): Structure of diindolylureas and diindolylthioureas binding to 
benzoate developed by Caltagirone et al. in 2008.59 (b): Top view of X-ray crystal 
structure of tetrabutylammonium benzoate complex of compound 12.59 
Furthermore, Caltagirone and co-workers later synthesised bis-2-amidoindole 
receptors of varying acidity coupled through 1,5-diaminopentane or 1,3-
phenylenediamine groups (Figure 1.8).73 1H NMR spectroscopic titrations in DMSO-
d6/0.5% H2O preferentially bound oxoanions, in particular H2PO4
-. Caltagirone et al. 
reported the formation of a 1:2 receptor:dihydrogen phosphate complex in solution 
with receptor 19 and in the solid state with receptor 16 evidence by X-ray 
crystallography (Figure 1.9).73 These results suggest a potentially useful strategy for 
complexing oxyanions containing both hydrogen bond donors and acceptors.  
 
10 
 
16: R = H
17: R = NO
2
18: R = H
19: R = NO
2  
Figure 1.8: Structure of 2-amidoindole receptors studied by Caltagirone and co-
workers in 2009.73 
 
Figure 1.9: Receptor 16 binding a dihydrogen phosphate dimer in the solid state.73 
  
1.5 Sulfonamide Based Anion Receptors 
In 2008, Caltagirone et al. reported urea receptors containing sulphonamide groups 
(Figure 1.10).74 Anion binding was monitored via 1H NMR spectroscopy in CD3CN 
and upon addition of Cl-, 1:1 complexes were formed with Ka values of 7550 M
-1 and 
>104 M-1 for 20 and 21 respectively. Upon addition 1 equivalent of AcO- or 2 
equivalents of F- the urea N-H resonance shifted downfield. It subsequently 
migrated upfield with further additions, due to decomplexation effects and 
deprotonation of the acidic sulfonamide N-H group. 
11 
 
 20  21
 
Figure 1.10: Structure of ureas containing sulfonamide groups observed to bind 
anions and which become deprotonated upon addition of further equivalents of 
basic anions.74 
Huggins et al. developed pyrrole sulfonamide based receptors 22-25 (Figure 1.11).6 
Anion binding titration studies carried out in dry CDCl3 showed 1:1 receptor:anion 
binding of 22-25 with a range of anions with Ka values up to 1768 M
-1. The 
sulfonamide N-H signals migrated further downfield compared to the pyrrole N-H 
protons. Further molecular modelling and 1H NMR spectroscopic studies confirmed 
that no change in conformation occurred upon anion binding. 
22: R = C
6
H
5
 
23: R = C
4
H
9
24: X = (CH
2
)
2
25: X = (CH
2
)
4  
Figure 1.11: Structure of pyrrole sulfonamide receptors developed by Huggins et al. 
in 2009.6 
 
1.6 Urea and Thiourea Based Anion Receptors 
Ureas and thioureas are attractive scaffolds for the design of anion receptors. They 
both contain two N-H fragments which can bind a single anion e.g. a halide anion or 
two adjacent oxygen atoms of an oxyanion.19, 75 Ureas and thioureas are the most 
widely employed hydrogen bond donor groups in anion receptor systems, due to 
their facile synthesis and easily tunable N-H acidity.76 In 1992, Smith and co. 
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workers reported a urea receptor 26 which was capable of binding anions such as 
carboxylates, phosphonates and sulfates (Figure 1.12).77 Kelly and Kim also 
developed a urea based receptor 27 which was capable of binding phosphonate 
and sulfate anions (Figure 1.12).78 
 Smith and co-workers
 26  27
 Kelly and Kim
 
Figure 1.12: Structure of urea based receptors studied by Smith et al.77 and Kelly 
and Kim.78 
Gunnlaugsson et al. developed naphthalimide thiourea based receptors 28 and 29 
which were reported to bind anions such as AcO-, F- and H2PO4
- in aqueous solution 
with an accompanying colour change (Figure 1.13).79 Ka values of approximately 10
4 
– 105 M-1 for AcO-, F- and H2PO4
- were observed with stronger binding for 29 than 
28. Deprotonation was observed in the presence of F- accompanied by colour 
changes which could not be reversed upon addition of water or ethanol. UV 
titrations in DMSO were consistent with anion complexation which required the syn 
orientation. X-ray crystallography also showed that the thiourea protons existed in 
the anti-conformation to carbonyl carbon with intermolecular interaction between 
adjacent molecules (Figure 1.13).79  
In 2005, Brooks et al. reported enhanced anion binding constants from receptors 
containing bis-urea groups linked by a 1,2-phenylenediamine spacer compared to 
non-urea based receptors 30 and 31 (Figure 1.14).80 1H NMR spectroscopic 
titrations in DMSO-d6/0.5% water showed that the bis-urea receptor 32 was 
selective for carboxylate anions with Ka values of 3210 M
-1 and 1330 M-1 for AcO- 
and BzO- respectively compared with 100 – 200 M-1 for non-urea based receptors 
30 and 31. 
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(a)                                                                    (b) 
28: R = CH
3
29: R = CF
3
                           
Figure 1.13 (a): Structure of naphthalimide thiourea based receptors developed by 
Gunnlaugsson et al.79 (b):  X-ray crystal structure of 28.79 
Significantly improved Ka values were obtained using a 4,5-dichloro-substituted 
central ring and a nitro group at the 2-position of the urea N-aryl rings 34 (Figure 
1.14).80, 81 Bis-thiourea based receptor 34 produced significantly lower Ka values, 
due to the large S atom changing the shape of the binding site which prevents 
binding to the outer N-H groups. X-ray crystallography showed that receptor 32 
binds anions through four H-bonds (Figure 1.15).80, 81  
 30  31  32: X = O
 33: X = S  34  
Figure 1.14: Structure of urea and thiourea based receptors studied by Brooks et 
al.80, 81 
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Figure 1.15: The benzoate complex of receptor 32 showing the formation of four 
hydrogen bonds between the receptor and the carboxylate anion in the solid 
state.80, 81 
 
1.7 Squaramide Based Anion Receptors 
Squaramides are four-membered ring systems derived from squaric acid which can 
form up to four H-bonds. Its carbonyl groups may act as H-bond acceptors while its 
N-H groups may act as H-bond donors. The physical properties of squaramides and 
their complexes with anions and cations have been discussed in several papers.82-85 
It was recognised that secondary squaramides offer the potential to hydrogen bond 
to acceptors, donors and to mixed acceptor-donor groups (Figure 1.16).84 
H-bond donor 
anti / anti
anti / syn
H-bond acceptor H-bond acceptor
 
Figure 1.16: Hydrogen bonding donor ability of squaramides.84 
The strong hydrogen bond donor ability of the squaramide functional group has 
been exploited in the design of anion receptors,83, 86-90 catalysts,91, 92 and self-
complementary recognition motifs.93 The squaramide group possesses remarkable 
hydrogen bonding donor and acceptor abilities and theoretical studies showed its 
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tendency to increase the aromaticity of the four-membered ring upon binding.82, 94 
This important feature along with directional hydrogen bond donor ability in the 
extended conformation make this structural motif a useful building block in the 
design of various synthetic receptors that have applications in the supramolecular 
chemistry field. Squaramides have found application in numerous contexts: they 
have been used as scaffolds for crystal engineering,95 as linkers for bioconjugation96 
and as emerging pharmacophores in medicinal chemistry.97-101  
35: R, X = tBu
36: R, X = Bu
37: R = Bn, X = CH
2
CH
2
NMe
2
38: R = Bn, X = NMe
3
+
39: R = NHC
6
H
11
 
40: R = NHBn
41: R = NHCH
2
CH
2
NMe
2
42: R = NHCH
2
CH
2
NMe
3
+
43: R = nPr, X = NHBn
 
 Figure 1.17: Structure of squaramide based receptors studied by Prohens et al.83 
In 1998, Prohens et al. studied the H-bonding capability of squaramide based 
receptors 35-43 (Figure 1.17).83 Upon the addition of tetramethylammonium (TMA) 
AcO- solution to squaramide based receptors receptors 35-38, characteristic shifts 
of both squaramidic and methylenic protons were observed. Neutral receptors 35-
37 showed moderate to good Ka values whereas the positively charged receptor 38 
produce an eight to ten fold increase in binding.83 Prohens et al. reported that 
16 
 
receptors 39-42 are appropriated for binding dicarboxylates derived from glutaric 
or glutaconic diacids.83  
In pure DMSO the Ka values of the complexes formed between the bis-
tetrabutylammonium (TBA) glutarate and receptors 39-42 are too large (>104 M-1) 
to be measured by NMR spectroscopy. However, the addition of water lowered the 
Ka values into a measurable range. Prohens et al. also reported an increase in 
binding constant for receptor 43 compared to receptors 39-42, which was due to 
the presence of an extra squaramide unit in receptor 43.83 
47: R = Me
3
N+
2 I-
45: R = Me
3
N+, X = OEt
46: R = Me
3
N+, X = NH(CH
2
)
3
NMe
2
2 I-
44: R = Me
3
N+
2 I-
 
2 I-
48: R = Me
3
N+, X = NH
49: R = Me
3
N+, X = CH
2
 
Figure 1.18: Positively charged squaramide receptors developed by Costa and co-
workers.87 
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Costa and co-workers conducted a thermodynamic study probing  the implications 
of binding of squaramides to carboxylates.102 It was observed that binding was 
exothermic in DMSO and chloroform.102 Whereas in methanol, the association was 
endothermic and driven by entropy due to the breakage of solvent interactions and 
release of solvent molecules to the bulk phase.102 Costa et al. later reported a range 
of positively charged SO4
2- selective squaramide receptors 44-49 which could bind 
SO4
2- and H2PO4
- in ethanol / water mixtures (Figure 1.18).87 
Furthermore, Ramalingam et al. developed squaramide molecules bearing carbonyl 
groups which could effectively open and close the anion binding cleft due to 
intramolecular interactions and application which was designed with anion 
transport in mind (Figure 1.19).90 In non-polar solvents, no Cl- binding was observed 
due to intramolecular H-bonding. In polar solvents, H-bonding was disrupted, 
resulting in a conformational change to occur and Cl- binding to proceed. 
50: X = COPh, Y = H, Z = H
51: X = COPh, Y = H, Z = Cl
52: X = H, Y = COPh, Z = H  
Figure 1.19: Squaramide based receptors studied by Ramalingam and co-workers.90 
There was no Cl- binding of 50 and 51 observed in CHCl3 whereas in CH3CN, both 
receptors bound anion with a 5-fold increase observed in Ka value for 51 over 50 as 
a result of chloro-substitution. The meta-isomer 52 of the non-chlorinated receptor 
50 bound anions in both polar and non-polar solvents with higher Ka values 
reported due to the lack of steric hindrance effects in receptor 52 compared to 
receptors 50 and 51. 
In 2010, Al-Sayah and Branda studied a thiourea 53 and a squaramide 54 bipyridine 
containing receptor for binding AcO- in a variety of solvents (Figure 1.20).103 In 1:1 
18 
 
CD3CN:CDCl3, thiourea 53 yielded a Ka value of 5790 M
-1 while the squaramide 54 
bound AcO- with a Ka value of 7390 M
-1.  
 53  54  
Figure 1.20: Structure of thiourea and squaramide based receptors developed by Al-
Sayah and Branda.103 
Amendola et al. compared the anion binding properties of the urea based receptor 
55 possessing an electron withdrawing NO2 group with a similar squaramide 
receptor 56 (Figure 1.21).61, 104 1:1 complexes were reported in all cases through 
UV/Vis and 1H NMR spectroscopy. According to the squaramide based receptor 56, 
H-bond interactions involved the N-H and also the closely located aryl C-H groups 
resulting in a total of four H-bonds.  
 55  56  
Figure 1.21: Structure of urea and corresponding squaramide based receptors 
studied by Amendola et al.61 
Squaramide receptor 56 complexes containing halides as guests were 
approximately 1 to 2 orders of magnitude more stable than urea based receptor 55. 
Both receptors 55 and 56 complexes of the same guest possessed approximately 
equal Ka values for oxyanions. For the most basic anions such as AcO
- and F- 
complexed with receptor 56, 1:1 H-bonding complexes were originally formed 
followed by N-H deprotonation. However, deprotonation did not occur for receptor 
55 with AcO-, due to its lower acidity. Amendola et al. concluded that squaramide 
based receptor 56 was a more efficient halide receptor while both receptors 55 and 
56 possessed similar tendencies towards oxyanions.  
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Rostami et al. reported a new synthetic procedure for the preparation of 
squaramide receptors and examined an acidic 4-nitroaniline derived squaramide 57 
(Figure 1.22) for its anion binding properties through UV/Vis spectroscopy.62 
Significant differences in UV spectra of 57 were observed in CH3CN compared to 
DMSO, which was due to deprotonation of one of the squaramide NH groups in 
DMSO without the addition of a base.62  
57  
Figure 1.22: Squaramide based receptor 57 which undergoes proton transfer events 
reported by Rostami et al.62 
The deprotonation was more evident with increasing dilution. It was proposed that 
the H-bond accepting ability of DMSO promoted this equilibrium process which 
became unfavoured at higher concentrations of 57 due to self-association. Addition 
of basic anions such as AcO- and H2PO4
- to a solution of 57 in DMSO did not impart 
in any spectral changes.62 However, addition of TBA fluoride induced deprotonation 
of the second squaramide NH group with an accompanying colour change.62 In 
acetonitrile, 57 existed in its neutral state with deprotonation induced upon 
addition of F-, AcO-, H2PO4
-, and p-toluenesulfonate. Interestingly, receptor 57 was 
observed to reprotonate upon addition of excess TBA tosylate following initial 
deprotonation.62 This effect was reported to be due to the formation of a stable 
double H-bonded complex which was more stable than the protonated form of 
DMSO.62 
Amendola and co-workers later conducted a thermodynamic study to compare the 
anion binding properties of urea 58, squaramide 59, and sulfonamide 60-62 based 
receptors using spectrophometric, isothermal titration calorimetry (ITC) and 1H 
NMR titrations in CH3CN (Figure 1.23).
104 The results showed that all receptors 58-
62 formed 1:1 H-bond complexes to Br- and Cl- with 59 producing the strongest 
binding.104 Receptors 58 and 59 formed extremely strong binding complexes with 
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AcO- while proton transfer effects were evident in the titration of sulfonamide 
receptors 60-62 with AcO-.104 Potentiometric studies of receptors 59-62 showed 
that the pKa values of 59, 60, 61 and 62 were 10.9, 8.3, 8.3 and 4.3 respectively.
104 
These results highlighted the enhanced acidity of 62 which was due the stabilising 
effect of the meta-NO2 groups on the negative charge formed through 
deprotonation.104 However a pKa value for 58 could not be calculated as this 
receptor did not deprotonate.104 
58 59
60 61
62  
Figure 1.23: Receptors studied by Amendola and co-workers.104 
In 2014, Gaeta et al. developed squaramidocalix[4]arene based receptors 63 and 64 
(Figure 1.24), in which two squaramide moieties were attached to the upper rim of 
the calix[4]arene scaffold.105  Spherical anions such as Cl- and Br- were found to 
induce dimerization of receptors 63 and 64, thus forming 2:1 calixarene-anion 
complexes as demonstrated by Job plots and electrospray ionization mass 
spectrometry (ESI-MS) data.105 However, the binding and dimerization with 
trigonal-planar anions such as BzO- and NO3
- was only observed for receptor 64. 
Gaeta reported this behaviour to be due to an intramolecular H-bond in receptor 64 
that favours binding with trigonal-planar anions via one squaramide moiety.105 
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63 64  
Figure 1.24: Structure of squaramidocalix[4]arene based receptors developed by 
Gaeta et al.105 
Elmes and co-workers studied the anion binding and spectroscopic sensing 
properties of squaramide-based anion receptors 65-68 (Figure 1.25), which showed 
the highly unusual behaviour of deprotonation by the relatively weakly basic Cl- 
anion in DMSO.106 Titration of 65-67 with Cl- led to dramatic changes in the colour 
of the solution and quenching of the excimer emission at 530 nm.  
65 66
67 68  
Figure 1.25: Squaramide based fluorescent anion sensors developed by Elmes et 
al.106 
On the basis of the disappearance of the NH 1H NMR resonances and colour 
changes induced by high concentrations of chloride, Elmes et al. proposed that 
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receptors 65-67 could be deprotonated by Cl- at high concentrations, whereas H-
bonding to Cl- occurred at low Cl- concentrations.106 However, deprotonation was 
not observed with less basic anions (Br-, I-, and NO3
-) or with the less acidic 
squaramide 68 in the presence of Cl-. X-ray analysis revealed that receptor 65 forms 
a 1:1 (receptor/anion) complex with Cl-, where the encapsulated anion is bound by 
two H-bonding interactions with both available squaramide NH groups (Figure 
1.26).106 
 
Figure 1.26: Single crystal X-ray structure of the chloride complex of receptor 65.106 
 
Elmes et al. later developed a series of thiosquaramides107 69-72 and 
oxothiosquaramide108 73 receptors that function as pH-dependent anion 
transporters (Figure 1.27). Titration binding studies with TBA Cl- by 1H NMR 
spectroscopy in DMSO-d6/0.5% H2O, fitted to a 1:1 binding model, derived the Ka of 
thiosquaramides 69-72 (60–400 M-1) and oxothiosquaramide 73 (470 M-1).107, 108 
The pH-dependent Cl- anion- transport activities were determined by using POPC 
liposomal Cl-/NO3
- exchange assay and monitored by chloride-ISE in phosphate 
buffer at pH 7.2 and citrate buffer at pH 4.0. Receptors 69, 70, and 73 were 
significantly more active at pH 4.0 than at pH 7.2.107, 108 However, thiosquaramides 
receptors 71 and 72 were inactive in both neutral and acidic media because 
lipophilicities were too high. pH-Spectrophotometric titration studies in CH3CN/H2O 
(9:1, v/v) demonstrated that the NH H-bond donors of receptors 69, 70, and 73 
were much more acidic than the respective analogous oxosquaramides.107, 108 The 
derived pKa values of receptors 69, 70 and 73 were 7.3, 5.3 and 6.6 respectively. 
This result provided evidence that these receptors were mainly deprotonated as 
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negatively charged species at neutral pH, hence transport activities were enhanced 
at pH 4.0 with the receptors in the neutral state.107, 108 
 
69 70
71 72
73  
 
Figure 1.27: (A) Structure of thiosquaramides receptors 69-72.107 (B) Structure of 
oxothiosquaramide receptor 73 studied by Elmes et al.108 (C) X-ray crystal structure 
of thiosquaramide receptor 70 with TMA chloride.107 
1.8 Conclusion 
This chapter gave a detailed insight on the significant role anions play in biology and 
in the environment. It also gave a brief introduction into how these anions can be 
A 
B 
C 
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selectively recognised by anion receptors via H-bonding. The design, synthesis and 
spectroscopic anion binding studies of our novel squaramide based  fluorescent 
receptors will be discussed in the next chapter. 
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Chapter 2 - Synthesis and Spectroscopic Anion Binding Studies of Potential Novel 
Squaramide Based Receptors 
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2.1 Introduction 
Squaramides have found application in a number of areas of chemical research 
from their use for bioconjugation109 to emerging pharmacophores in medicinal 
chemistry.110 The strong hydrogen bond donor ability of the squaramide functional 
group has also recently been exploited in supramolecular chemistry for the design 
of anion receptors,62 self-complementary molecular recognition motifs,93 and 
catalysis.111  
 
Figure 2.1: Schematic representation of potential squaramide based anion 
receptors. 
Research in the Elmes group has centered on the development of napthalimide 
based fluorescent anion receptors and sensors, (Figure. 2.1), with potential uses in 
numerous biomedical and environmental applications.106, 112 In particular, we have 
focused on receptors capable of selectively recognising sulfate due to its major role 
as a ground water contaminant in mining associated water pollution and in 
proposed radioactive waste-treatment processes.113 In any case, binding of anions 
to receptors via H-bonding can lead to favourable applications in environmental 
chemistry and potential applications as emerging pharmacophores in medicinal 
chemistry.101, 106 With this in mind, the overall aim of the work presented in this 
Chapter is to identify the potential of compounds 85 - 88 as fluorescent receptors 
and also as possible anion sensors (Figure 2.2). 
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Figure 2.2: Structure of target squaramide based fluorescent anion receptors 85 - 
88. 
 
2.2 Design Requirements 
The design of the novel receptors will be based on four different requirements 
which include; the binding site, the signalling unit, the electron withdrawing group 
(EWG) and the position of the binding site. 
2.2.1 The Binding Site 
In the design of our novel receptors, we foresaw that the remarkable hydrogen 
bonding donor ability of the squaramide motif could be utilised. The four 
membered ring conjugated diamines derived from squaric acids, have the capacity 
for selectively binding to different H-bond acceptors through their acidic N-H 
groups (Figure 2.3). Therefore due to this reason, we decided to exploit the strong 
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hydrogen bond donor ability of the squaramide motif in the design of our novel 
receptors.  
H-bond donorH-bond donor 
H-bond acceptor H-bond acceptor
 
Figure 2.3: Hydrogen bonding donor ability of squaramides.84  
2.2.2 The Signalling Unit 
In the design of our novel receptors, we foresaw that the set of known 
photophysical properties provided by the naphthalimide fluorophore could be used 
to monitor the anion binding process of our novel receptors. The naphthalimide 
structure has found application in many areas of chemistry, ascribed to its unique 
photophysical properties.114-117 Its absorption and fluorescence emission spectra lie 
within the UV/Vis regions and the various photophysical properties can be adjusted 
through rational structural design.118 The electron donating amine and the electron 
withdrawing imide of the 4-amino-1,8-naphthalimide results in a ‘push – pull’ 
based, internal charge transfer (ICT) (Figure 2.4).118 The ICT character, gives rise to a 
large excited-state dipole and, in turn, broad absorption and emission bands 
centred at 450 and 550 nm respectively when recorded in water.118 The potential of 
the highly versatile 4-amino-1,8-naphthalimide signalling unit that absorbs and emit 
at long wavelengths was employed for as the signalling unit for the anion sensing of 
our novel receptors. 
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Figure 2.4: Structure of 4-amino-1,8-naphthalimide and the schematic 
representation of the ICT excited state within the 4-amino-1,8-naphthalimide 
fluorophore caused by a ‘push – pull’ action.118 
2.2.3 The Electron Withdrawing Group (EWG)  
It was anticipated that the presence of electron-withdrawing groups (EWG) would 
increase the acidity and the H-bonding capability of the N-H hydrogen bond donor 
of the squaramide motif, as has been previously seen with receptors 57, 59, 65 and 
67.62, 65, 67, 104 Therefore, it was also predicted that the presence of EWG could 
improve the anion binding affinities towards our novel receptors. The electron-
withdrawing abilities of the trifluoromethyl and nitro substituents were explored 
for this purpose (Figure 2.5). 
 
Figure 2.5: Schematic representation of the EWG employed for the receptor design. 
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2.2.3 The Binding Site Position  
In the design of our novel receptors, we varied the position of our binding site by 
attaching the binding site to either the top or the bottom of the signalling unit as 
shown in Figure 2.6. The position of the binding site was altered from the bottom to 
the top of the signalling unit in order to observe any changes in the binding affinity 
of our novel receptors. 
 
Figure 2.6: Schematic representation of the binding site postion (Top or Bottom) on 
the signalling unit for the receptor design. 
In the following chapter, the description of the synthesis and characterisation of 
each of the compounds 85 - 88 will be given. This will be followed by a discussion of 
the photophysical properties of each compound and their anion binding behaviour 
which may be established using a range of different spectroscopic techniques.  
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2.3 Synthesis  
The target compounds 85 - 88 were prepared from commercially available starting 
materials. All target and intermediates compounds were fully characterised using 
1H NMR, 13C NMR, infrared spectroscopy and high resolution mass spectroscopy. 
2.3.1  Synthesis of Novel Compounds 85 and 86 
The synthesis of compound 85 was achieved using intermediates 75 and 79 in the 
synthetic pathway of 85 as outlined in Scheme 2.4. Firstly, intermediate 75 was 
synthesised as outlined in Scheme 2.1, by stirring a solution of 3,5-
bis(trifluoromethyl)aniline in EtOH with a solution of diethyl squarate 74 and zinc 
triflate to ensure that 74 was electrophilic enough prior to nucleophilic attack by 
bis(trifluoromethyl)aniline in EtOH. Removal of solvent by filtration yielded the 
desired product 75 as an off-white amorphous solid in 79% yield. 
 
 
Scheme 2.1: Synthetic pathway to 75 (i) Zn(OTf)2, EtOH. 
 
 
Scheme 2.2: Synthetic pathway to 76 (i) Zn(OTf)2, EtOH 
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Scheme 2.3: Synthetic pathway to 79 (i) Ethylamine, EtOH, reflux; (ii) 
Ethylenediamine. 
 
 
Scheme 2.4: Synthetic pathway to 85 (i) Et3N, EtOH. 
 
 
Scheme 2.5: Synthetic pathway to 86 (i) Et3N, EtOH. 
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Intermediate 79 was synthesised according to Scheme 2.2, by direct amination of 
78 using ethylenediamine at room temperature to yield 79 as a yellow amorphous 
solid in 80% yield. Finally, receptor 85 was synthesised as outlined in Scheme 2.4, 
via the nucleophilic addition of intermediates 75 to 79 in Et3N and EtOH to yield 
receptor 85 as a yellow amorphous solid in 78% yield. The same procedure was 
applied to synthesis of compound 86 using intermediate 76 instead of intermediate 
75 as outlined in Scheme 2.5. Compound 86 was obtained as an orange amorphous 
solid in 73% yield. Novel receptors 85 and 86 were fully characterised by 1H NMR, 
13C NMR, HRMS and IR spectroscopy. The 1H NMR spectrum of 85 at 293 K is shown 
in Figure 2.7. 
The 1H NMR spectrum of 85 and 86 at 293 K in DMSO-d6 could not be accurately 
assigned due to peak broadening observed in both the 1H NMR spectrum of 85 and 
86 at 293 K in DMSO-d6. This observation was proposed to be ascribed to a self-
association interaction between the receptor molecules. Therefore, the 1H NMR 
analysis of 85 and 86 at 343 K was considered to aid in the accurate 
characterisation of 85 and 86 in DMSO-d6.  
 
 
 
(A) 
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Figure 2.7: (A) The 1H NMR spectrum of compound 85 at 293 K (500.13 MHz, DMSO-
d6). (B) The zoomed in 
1H NMR spectrum of the aromatic region of compound 85 at 
293 K (500.13 MHz, DMSO-d6). 
As shown in Figure 2.8, the 1H NMR spectrum of receptor 85 at 343 K resulted in 
sharper peaks of all the signals observed for compound 85 at room temperature. 
The 1H NMR peaks were assigned using 2-D C-H and H-H COSY analysis, the results 
of which correlated to the expected number of protons, integration and chemical 
shifts were appropriate. Resonances corresponding to both the 1,8-naphthalimide 
and the trifluomethyl aromatic moieties are evident, in addition to those for the 
squaramide anion binding site. Successful formation of compound 85 was also 
evident from accurate mass spectrometry, where 85 displayed a peak at 591.1439 
corresponding to the [M + H] ion (-3.8 ppm). 
(B) 
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Figure 2.8: (A) The 1H NMR spectrum of compound 85 at 343 K (500.13 MHz, DMSO-
d6). (B) The zoomed in 
1H NMR spectrum of the aromatic region of compound 85 at 
343 K (500.13 MHz, DMSO-d6). 
 
(A) 
(B) 
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2.3.2  Synthesis of Novel Compounds 87 and 88 
An alternative synthetic strategy was utilised in the synthesis of compounds 87 and 
88, in which the binding site is attached to the top position of the signalling unit. 
The synthesis of compounds 87 was achieved using intermediates 75 and 84 in the 
synthetic pathway of 87 as outlined in Scheme 2.7. Firstly, intermediate 75 was 
synthesised as outlined in Scheme 2.1. Intermediate 84 was synthesised according 
to Scheme 2.6, by direct amination of 80 using Boc-protected ethylenediamine 
(tert-butyl(2-aminoethyl)carbamate) 81 in EtOH by heating under microwave 
reaction conditions (1 hour at 110°C, 1 mbar, 300 Watts). The extraction the organic 
layer with de-ionised H2O, followed by the removal of the solvent under reduced 
pressure, yielded the desired product 82 as a peach amorphous solid in 76% yield.  
 
Scheme 2.6: Synthetic pathway to 84 (i) EtOH, Microwave (1 hour at 110°C, 1 mbar, 
300 Watts); (ii) TFA:DCM,  (50:50) (iii) Pd/H2, MeOH. 
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Scheme 2.7: Synthetic pathway to 87 (i) Et3N, EtOH. 
The de-protection of 82 in a mixture of TFA : DCM (50 : 50) yielded 83 as a beige 
amorphous solid in 93% yield. Reduction of the nitro group of 83 using Pd/H2 in 
MeOH, gave the pure diamine 84 as a mustard solid in 75% yield. Finally, compound 
87 was synthesised as outlined in Scheme 2.6, via the nucleophilic addition of 
intermediates 75 and 84 in Et3N and EtOH to yield receptor 87 as an olive green 
solid in 56% yield. The same procedure was applied to synthesis of compound 88 
using intermediate 76 instead of intermediate 75 as outlined in Scheme 2.2. 
Receptor 88 was obtained as an orange solid in 67% yield. Novel compounds 87 and 
88 were fully characterised by 1H NMR, 13C NMR, HRMS and IR spectroscopy. The 1H 
NMR spectrum of 87 at 293 K is shown in Figure 2.9. 
Analogous to compound 85 and 86, the 1H NMR spectra of 87 and 88 at 293 K in 
DMSO-d6 could not be accurately characterised due to peak broadening observed in 
both the 1H NMR spectra of 87 and 88 at 293 K in DMSO-d6. This observation was 
also predicted to be due to self-association interaction between the receptor 
molecules. Therefore, similar to compounds 85 and 86, the 1H NMR analysis of 87 
and 88 at 343 K was considered to aid in the accurate characterisation of 87 and 88 
in DMSO-d6. As shown in Figure 2.10, the 
1H NMR spectrum of compound 87 at 343 
K also resulted in sharper peaks of all the signals observed for compound 87 at 
room temperature. The 1H NMR peaks were assigned using 2-D C-H and H-H COSY 
analysis, the results of which correlated to the expected number of protons, 
integration and chemical shifts were appropriate. Resonances corresponding to 
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both the 1,8-naphthalimide and the trifluomethyl aromatic moieties are evident, in 
addition to those for the squaramide anion binding site. Successful formation of 
receptor 87 was also evident from accurate mass spectrometry, where 87 displayed 
a peak at 565.1231 corresponding to the [M + H] ion (4.31 ppm). 
 
 
 
Figure 2.9: (A) The 1H NMR spectrum of compound 87 at 293 K (500.13 MHz, DMSO-
d6). (B) The zoomed in 
1H NMR spectrum of the aromatic region of receptor 87 at 
293 K (500.13 MHz, DMSO-d6). 
(A) 
(B) 
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Figure 2.10: (A) The 1H NMR spectrum of compound 87 at 343 K (500.13 MHz, 
DMSO-d6). (B) The zoomed in 
1H NMR spectrum of the aromatic region of receptor 
87 at 343 K (500.13 MHz, DMSO-d6). 
In summary, the position of the binding site (bottom or top) to the signalling unit 
did not hinder the successful synthesis of compounds 85 – 88. The analysis of the 1H 
NMR spectra at 343 K of compounds 85 – 88 in DMSO-d6 resulted in better 
(A) 
(B) 
40 
 
resolution which was attributed to peak sharpening of the characteristic peaks of 
compound  85 – 88 at 293 K. However, the 1H NMR spectra of compounds 85 – 88 
in DMSO-d6 could not be accurately assigned at 293 K due peak broadening of the 
characteristic peaks of compounds 85 – 88. This observation was proposed to be 
attributed to self-association interaction between the potential receptor molecules 
of 85 – 88. With this in mind, potential self-association ability of compounds 85 – 88 
will be investigated next via scanning electron microscopy (SEM). 
 
2.4  Scanning Electron Microscopy (SEM)  
The potential self-association ability of compounds 85 – 88 was investigated using 
SEM analysis. Interesting patterns were observed in the SEM images of compound 
85, 86, 87 and 88 as shown in Figures 2.11, 2.12, 2.13 and 2.14 respectively. These 
unique patterns further confirms our prediction of self-association interaction 
between compounds 85 – 88 molecules from the 1H NMR broadened spectra of 85 - 
88 at 293 K in DMSO-d6. 
 
Figure 2.11: Scanning electron microscopy (SEM) images  of compound  85 spotted 
with Au, (A): Mag x 100; (B): Mag x 200; (C): Mag x 1000; (D): Mag x 4000; (E): Mag 
x 7000. 
41 
 
 
Figure 2.12: Scanning electron microscopy (SEM) images  of compound  86 spotted 
with Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 1000; (D): Mag x 1800; (E): Mag 
x 4000; (F): Mag x 7000. 
 
 
Figure 2.13: Scanning electron microscopy (SEM) images  of compound  87 spotted 
with Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 500; (D): Mag x 1000; (E): Mag 
x 4000; (F): Mag x 7000. 
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Figure 2.14: Scanning electron microscopy (SEM) images  of compound  88 spotted 
with Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 1000; (D): Mag x 4000; (E): Mag 
x 7000. 
In summary, 1H NMR analysis at 293 K in DMSO-d6 and SEM analysis revealed the 
presence of self-association interaction between the molecules of potential 
receptors 85 – 88. However, upon increasing the temperature, it was observed that 
molecules of potential receptors 85 – 88 self-dissociates from each other. This was 
supported by the increase in resolution and the sharpening of characteristic peaks 
in the 1H NMR spectra of compounds 85 – 88 at 343 K in DMSO-d6. The 
photophysical characterisation of compounds 85 – 88 will be discussed next. 
 
2.5  Photophysical Characterisation  
Characterisation of the photophysics of novel compounds 85 – 88 was undertaken 
in order to fully understand their photophysical behaviour necessary to monitor the 
interaction of such systems with anions. 
2.5.1  Photophysical Characterisation of Novel Compound 85 
The UV/Vis absorption spectrum of compound 85 in DMSO (0 – 57 µM) is shown in 
Figure 2.15. Three different absorption maxima are shown in the UV/Vis absorption 
spectrum at 280 nm, 340 nm and 445 nm with extinction coefficient values of 
32642 M-1, 19559 M-1 and 15439 M-1  respectively as shown in Table 2.1. The 
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intense band at 280 nm is attributed to 𝜋 - 𝜋* transition with the naphthalimide 
fluorophore. The less intense bands at 340 nm and 445 nm are attributed to the 
internal charge transfer (ICT), which is a well documented feature of the 
naphthalimide fluorophore. 
Figure 2.15: Changes in UV/Visible spectra upon increasing concentration of 85 in 
DMSO (0 – 57 µM). Inset: Plot of absorbance at 445 nm as a function of  increasing 
concentration of 85. 
 
2.5.2  Photophysical Characterisation of Novel Compound 86 
The UV/Vis absorption spectrum of compound 86 in DMSO (0 – 67 µM) is shown in 
Figure 2.16. Two different absorption maxima are shown in the UV/Vis absorption 
spectrum at 280 nm and 420 nm with extinction coefficient values of 34375 M-1 and 
29899 M-1 respectively as shown in Table 2.1. The intense band at 280 nm is 
attributed to 𝜋 - 𝜋* transition with the naphthalimide fluorophore. The band at 420 
nm is attributed to the internal charge transfer (ICT) within the naphthalimide 
fluorophore. 
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Figure 2.16: Changes in UV/Visible spectra upon increasing concentration of 86 in 
DMSO (0 – 67 µM). Inset: Plot of absorbance at 420 nm as a function of  increasing 
concentration of 86. 
 
2.5.3  Photophysical Characterisation of Novel Compound 87 
The UV/Vis absorption spectrum of compound 87 in DMSO (0 – 60 µM) is shown in 
Figure 2.17. Three different absorption maxima are shown in the UV/Vis absorption 
spectrum at 280 nm, 340 nm and 445 nm with extinction coefficient values of 
34785 M-1, 20405 M-1 and 13717 M-1  respectively as shown in Table 2.1. The 
intense band at 280 nm is attributed to 𝜋 - 𝜋* transition with the naphthalimide 
fluorophore.118 The less intense bands at 340 nm and 445 nm is nm is attributed to 
the internal charge transfer (ICT) within the naphthalimide fluorophore. 
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Figure 2.17: Changes in UV/Visible spectra upon increasing concentration of 87 in 
DMSO (0 – 60 µM). Inset: Plot of absorbance at 445 nm as a function of  increasing 
concentration of 87.  
 
2.5.4  Photophysical Characterisation of Novel Compound 88 
The UV/Vis absorption spectrum of compound 88 in DMSO (0 – 70 µM) is shown in 
Figure 2.18. Two different absorption maxima are shown in the UV/Vis absorption 
spectrum at 280 nm and 420 nm with extinction coefficient values of 35187 M-1 and 
27410 M-1 respectively as shown in Table 2.1. The intense band at 280 nm is 
attributed to 𝜋 - 𝜋* transition with the naphthalimide fluorophore. The band at 420 
nm is attributed to the internal charge transfer (ICT) within the naphthalimide 
fluorophore. A third absorption maxima at 545 nm attributed to the naphthalimide 
𝜋 – 𝜋 stacking band was also observed in the UV/Vis absorption spectrum of 
compound 88.79, 118, 119 However, the naphthalimide 𝜋 – 𝜋 stacking band at 545 nm 
does not obey the Beer-Lambert law which further suggests the presence of a self-
association interaction within the molecules in compound 88. A summary of the 
absorption properties of potential anion receptors 85 - 88  as well as their molar 
absorptivities is given in Table 2.1. 
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Figure 2.18: Changes in UV/Visible spectra upon increasing concentration of 88 in 
DMSO (0 – 70 µM). Inset: Plots of absorbance at (a) 545 nm and (b) 420 nm as a 
function of  increasing concentration of 88. 
Table 2.1: Absorption properties of potential anion receptors 85, 86, 87 and 88 in 
DMSO 
Receptor λmax (nm) [ε(M
-1 cm-1) in DMSO (3mL) 
𝛑 - 𝛑*   ICT 
85 280 [32642] 340 [19559] 445 [15439] 
86 280 [34375] - 420 [29899] 
87 280 [34785] 340 [20405] 445 [13717] 
88 280 [35187] - 420 [27410] 
 
In summary, 85 – 88 display varied and potentially useful photphysical properties in 
DMSO. They possess multiple absorption bands which are expected to be sensitive 
to their environment and, thus, are expected to change upon intraction with 
anions. Furthermore, receptor 85 and 87 are more emissive in DMSO solution and 
as such it is anticipated that, the interruption of the quenching process upon anion 
binding may lead to a switch on and switch off effect being exhibited. This 
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behaviour is in contrast to compounds 86 and 88 which are less emissive in DMSO 
solution. The nature of the interactions of compounds 85 - 88 with anions will be 
dicussed in the following sections and will form the basis of this study of a novel set 
of flourescent receptors for targeting anions. 
 
2.6  Anion Binding Studies 
It has been observed that squaramides exhibit significantly higher H-bonding 
abilities compared to their urea and thiourea analogues82, 94 and that this results in 
superior anion binding affinities.61, 104, 106, 112  Hence, spectroscopic titrations of 
receptor 85 – 88 with different anions were carried out to investigate the nature 
and binding affinity of these receptors with anions. These results are presented and 
discussed in the following sections. 
2.6.1  Spectroscopic Titrations of Novel Compounds 85 – 88 
2.6.1.1  UV/Vis Absorption Titrations of Novel Compounds 85 – 88 with Anions 
(AcO-, Cl-, F-, PO4
3- and SO4
2-) in DMSO 
The interaction of 85 – 88 with anions was firstly examined using UV/Vis 
spectroscopy. The titrations were performed by additions of aliquots of the 
putative anionic guest (AcO-, Cl-, F-, PO4
3-, SO4
2-) as the tetrabutylammonium (TBA) 
salt solutions (20 mM made up in 1.199 × 10-5 M solutions of the receptors in 
DMSO) to a 1.199 × 10-5 M solution of the receptor in DMSO. Typically, up to 70 
equivalents of the salts were added. The changes in the UV bands upon anion 
addition were monitored for each receptor. All titration experiments were run in 
duplicate and where contrasting results were obtained triplicate experiments were 
conducted. The overall changes in the ground state of 88 with TBA sulphate are 
shown in Figure 2.20., with those of 85, 86 and 87 shown in the Appendix. 
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Figure 2.20: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing 
TBA sulphate equivalents in DMSO (0 - 70 eqs). Inset:  Plot of the change in 
absorbance at 420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of 
increasing TBA sulphate equivalents. 
Figure 2.21: Changes in the UV/Visible spectrum of 88 (11.9 µM, DMSO) with 70 
equivalents (700 µM) of different solution of anions as TBA salts in DMSO ( AcO-, Cl-, 
F-, PO4
3- and SO4
2-). 
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Figure 2.22: (A) Bind fit graph of UV titration of 88 (11.9 µM, DMSO) with increasing 
TBA sulphate equivalents in DMSO (0 - 70 eqs). (B) The speciation distribution 
diagram derived from the fitting of the changes in the absorption titration of 88 
(11.9 µM, DMSO) with TBA sulphate in DMSO (0 - 70 eqs), showing the formation of 
a 1 : 1 binding isotherm for 88 with TBA sulphate. 
Upon titration of receptors 85 – 88 with Cl- very minor changes were seen in the 
absorprtion spectra of 85 – 88 suggesting that little interaction with Cl- is occuring 
at the squaramide. In contrast, much more significant changes were seen 
absorprtion spectra of 85 – 88 upon addition of AcO-, F-, PO4
3- and SO4
2-. The 
(B) 
(A) 
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absorption spectra of 88 changed significantly upon incremental addition of SO4
2- 
with an increase in absorption of its band at 545 nm being observed and a 
concomitant decrease in the band at 280 nm and 420 nm also resulting in an 
isobestic point at 460 nm. Similar changes were observed in the absorption spectra 
of 88 upon incremental addition of AcO-, F- and PO4
3- as shown in Figure 2.21. These 
results suggest the occurrence of a deprotonation event at the squaramide binding 
site, upon the incremental addition of AcO-, F-, PO4
3- and SO4
2-. The data from the 
UV/Vis absorption titrations were next analysed in order to obtain a binding affinity 
for the anions of interest. To determine association constants Ka, for the receptor-
anion complexes, global analysis of the absorbance data was carried out using the 
open access BindFit software program120 as shown in Figure 2.22. A representative 
plot of absorbance vs concentration for 88 is shown as an inset in Figure 2.20 and a 
summary of the results obtained from the global analysis of the absorbance data of 
receptors-anion complexes of 85 – 88 are detailed in Table 2.2.  
Table 2.2: Summary of the anion association constants Ka (M
-1) of receptors 85 – 88 
in DMSO acoording to the UV anion titration data. 
Receptor Ka of receptors with anions [M
-1 (% error)] 
AcO- Cl- F- PO4
3- SO4
2- 
85 _a _b _a 3.6 x 104 
(10.4 %) 
4.6 x 103 
(15.8 %) 
86 _a _b _a 4.5 x 104 
(23.1 %) 
1.2 x 104 
(17.4 %) 
87 _a _b _a 2.0 x 104 
(8.1 %) 
1.2 x 104 
(15.3 %) 
88 _a _b _a 1.7 x 104 
(3.7 %) 
1.7 x 104 
(3.7 %) 
a The changes observed were associated with deprotonation of receptors 85 – 88, 
therefore the association constant Ka (M
-1) was not determined. b The changes 
observed in the UV data prevented accurate determination of the association 
constant because Cl- does not cause deprotonation of receptors 85 – 88. 
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2.6.1.2 Fluorescence Emission Titrations of Novel Compounds 85 – 88 with Anions 
(AcO-, Cl-, F-, PO4
3- and SO4
2-) in DMSO 
The interaction of 85 – 88 with anions was also examined using fluorescence 
spectroscopy. The titrations were performed by additions of aliquots of the 
putative anionic guest (AcO-, Cl-, F-, PO4
3-, SO4
2-) as the tetrabutylammonium (TBA) 
salt solutions (20 mM made up in 1.199 × 10-5 M solutions of the receptors in 
DMSO) to a 1.199 × 10-5 M solution of the receptor in DMSO. Typically, up to 70 
equivalents of the salts were added. The changes in the emission intensity upon 
anion addition were monitored for each receptor. All titration experiments were 
run in duplicate and where contrasting results were obtained triplicate experiments 
were conducted. The overall changes in the emission spectra of 85 with TBA 
sulphate are shown in Figure 2.23., with those of 85, 86 and 87 shown in the 
Appendix. 
Figure 2.23: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 
360 nm with increasing TBA acetate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
emission intensity at 522 nm as a function of TBA acetate equivalents. 
Minor changes were observed in the emission spectra of 85 – 88 upon titration with 
Cl-. Titration with AcO-, F-, PO4
3- and SO4
2-, however, led to much more significant 
changes as shown in Figure 2.23 for titration of SO4
2- with 85, where fluorescence 
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quenching was observed. The observed emission centred at 360 nm was 
significantly “switched off” by the presence of AcO-, F-, PO4
3- and SO4
2- ions. A 
similar effect was observed for 87 at an emission centred at 355 nm. However, a 
smaller emission decrease was exhibited for receptor 86 and 88 emission centred at 
430 nm and 460 nm respectively. Furthermore, the decrease in fluorescence of 85 
upon incremental addition of SO4
2-, also suggests the possible occurrence of some 
deprotonation events. 
2.6.2 1H NMR Spectroscopic Studies of Novel Compounds 85 – 88 with Anions 
(AcO-, Cl-, F-, PO4
3- and SO4
2-) in DMSO-d6. 
1H NMR titrations were conducted in order to further investigate the anion binding 
behaviour of 85 – 88. 1H NMR spectroscopic investigations of receptors 85 – 88 in 
DMSO-d6 (2.5 × 10
-3 M) with putative anionic guest (AcO-, Cl-, F-, PO4
3-, SO4
2-) as the 
TBA salt solutions (200 mM made up in 2.5 × 10-3 M solutions of the receptors in 
DMSO-d6) was performed, to understand the mechanism of the host – guest 
interactions. Figure 2.24 (a) shows the changes observed in the 1H NMR spectrum 
of 85 upon the addition of 20 equivalents of anions as TBA salts in a DMSO-d6 
solution of 85 (AcO-, Cl-, F-, PO4
3-, SO4
2-). Dramatic, changes were observed in the 1H 
NMR spectra of 85 - 88 upon the addition of 20 equivalents of AcO-, F-, PO4
3- and 
SO4
2- in a DMSO-d6 solution of 85 - 88, addition of these anions (AcO
-, F-, PO4
3- and 
SO4
2-) led to the disappearance of the NH signal (Ha) as shown in Figure 2.24 (a) for 
85. Stark colour changes of the solutions of 85 and 87 were observed upon the 
addition of F- under “naked eye” and UV illumination, although the addition of  AcO-
, PO4
3- and SO4
2- only led to major colour changes under UV illumination as shown 
in Figure 2.25 (a) and (b) for receptor 85. However, the solutions of 86 and 88 only 
showed stark colour changes under “naked eye”, upon the addition of AcO-, Cl-, F-, 
PO4
3- and SO4
2-, but no colour changes under UV illumination was observed. This 
was ascribed to the non-fluorescent nature of the receptors 86 and 88 with the 
nitro aryl substistuent. The disappearance of NH signal (Ha) in 
1H NMR spectra of 85 
– 88 and the stark colour changes upon the addition of AcO-, F-, PO4
3- and SO4
2- 
suggests that deprotonation event is responsible for the colour changes and NH 
signal loss as observed with the addition of AcO-, F-, PO4
3- and SO4
2- to 85 – 88. We 
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further confirmed this deprotonation behavior by the presence of bifluoride (HF2
-) 
in the 1H NMR spectrum of 85 – 88 upon the addition of F- as shown Figure 2.24 (b) 
for receptor 85.121, 122 
 
Figure 2.24: Changes in the 1H NMR spectrum of 85 (2.5 × 10-3 M) upon the addition 
of 20 eqvivalents of anions as TBA salts in a DMSO-d6 solution of 85 (AcO
-, Cl-, F-, 
PO4
3- and SO4
2-). (a): Aromatic region of 85. (b): Formation of HF2 upon the addition 
of 20 equivalents TBA fluoride to 85 in DMSO-d6.
121, 122 The differing spectroscopic 
response of compound 85 upon the addition of 20 eqvivalents of anions as TBA salts 
in a DMSO-d6 solution of 85 (AcO
-, Cl-, F-, PO4
3- and SO4
2-).  
(a) 
(b) 
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Moreover, interesting changes were observed in the 1H NMR spectra of 85 - 88 
upon the addition of 20 eqvivalents of Cl- in a DMSO-d6 solution of 85 – 88. The 
addition of Cl- led to the dramatic downfield shift of the NH signal (Ha) from 10.3 
ppm to 11.8 ppm as shown in Figure 2.24 (a) for 85. Subtle colour changes from 
yellow to bright yellow of the solutions of 85 and 87 were observed upon the 
addition of Cl- under UV illumination, as shown in Figure 2.25 (a) and (b) for 
receptor 85. The dramatic downfield shift of the NH signal (Ha) in the 
1H NMR 
spectra of 85 – 88 and the subtle colour change from yellow to bright yellow, upon 
the addition of Cl- to 85 and 87 suggests a binding interaction between Cl- and novel 
receptors 85 – 88. To further investigate the binding interaction of Cl- with 
receptors 85 – 88, 1H NMR spectroscopic titrations of 85 – 88 with TBACl was 
conducted. 
 
 
Figure 2.25: Changes in the appearance of a sample of 85 (2.5 × 10-3 M) upon the 
addition 20 eqvivalents of anions as TBA salts in a DMSO-d6 solution of 85 ( AcO
-, Cl-, 
F-, PO4
3- and SO4
2-). (a) With the naked eye and (b) Under UV illumination. 
2.6.2.1 1H NMR Spectroscopic Titration of 85 – 88 with TBACl in DMSO-d6 
We performed 1H NMR spectroscopic investigations in DMSO-d6 with each of the 
receptors 85 – 88 to establish the stoichiometry of their anion complexes with Cl-, 
(a) 
(b) 
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while gaining an understanding of host–guest interaction. Similarly, we sought to 
investigate the effect of the electron-withdrawing trifluoromethyl and nitro 
substituents on receptors 85 – 88. 1H NMR titrations of receptors 85 – 88 with Cl- 
were performed by additions of aliquots of the putative anionic guest as TBACl in a 
DMSO-d6 solution of 85 – 88 (20 equivalents) to a 2.5 × 10
-3 M solution of the 
receptor in DMSO- d6. The data obtained from these titrations were plotted as 
cumulative changes in chemical shifts (Δδ) against the equivalents of Cl- anions 
added and the resulting data were analyzed using the open access BindFit software 
program as previously described.120 
 
 
Figure 2.26: (a): Structure of 85 showing the NH proton as Ha. (b): Changes in the 
1H NMR spectrum (Ha proton) of 85 (2.5 × 10-3 M) upon the addition 0 - 20 
eqvivalents of anions as TBA chloride in a DMSO-d6 solution of 85. 
(a) 
(b) 
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Figure 2.27: (a):  Bind fit graph of the chemical shift of Ha proton (ppm) of 85 (2.5 × 
10-3 M, DMSO-d6)  with increasing TBA chloride equivalents in a DMSO-d6 solution of 
85 (0 - 70 eqs).  (b): The speciation distribution diagram derived from the fitting of 
the changes in the chemical shift of Ha proton (ppm) of 85 (2.5 × 10-3 M, DMSO-d6)  
with TBA chloride (0 - 70 eqs), showing the formation of a 1 : 1 binding isotherm for 
85 with TBA chloride. 
(a) 
(b) 
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Figure 2.26 (b) shows the changes observed in the 1H NMR spectrum of 85 upon the 
addition of Cl- (20 equiv.). A gradual downfield shift of the NH signal (Ha) from 10.2 
ppm to 11.8 ppm in the 1H NMR spectrum 85 was observed upon the increasing 
concentration of Cl-. These changes together with the subtle colour changes of 
these compounds observed upon the addition of Cl-, clearly support a classical H-
bonding interaction between Cl and the NH protons (Ha) of the receptors at low Cl
- 
concentrations (Figure 2.28).  
 
Figure 2.28: Possible chloride binding modes for receptors 85 and 87 based on 
UV/Vis, fluorescence and 1H NMR titration studies.  
The changes observed in the 1H NMR spectra of receptors 85 – 88 upon the 
addition of TBACl showed that the NH (Ha) signals associated with the squaramide 
NHs were significantly shifted downfield. Unepectedly however, the NO2 
substituted receptors 86 and 88 did not exhibit an increase in fluorescence  and 
showed lower binding affinities for Cl- than both 85 and 87 respectively. Morever, 
while CF3 substituted receptors 85 and 87 showed higher affinities for Cl
- than their 
NO2 substituted counterparts 86 and 88, 87 showed a slightly lower affinities for Cl
- 
than 86. The association constants (Ka) of 85 – 88 in DMSO-d6 (determined by 
BindFit) with Cl- are summarised in Table 2.3 and the number of the electron 
withdrawing substituents on the squaramide unit results in higher affinities for Cl-.  
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Table 2.3: Summary of the chloride association constants Ka (M
-1) of receptors 85 – 
88 in DMSO-d6 at 273 K according to the 
1H NMR titration Cl- data 
Receptor Ka (M
-1) % Error 
85 488.62 6.3 % 
86 273.65 4.1 % 
87 221.26 9.1 % 
88 114.80 5.9 % 
 
The relative position of the squaramide group with the electron withdrawing group 
attached on the receptor also play a major role in the strength of the association 
constant with Cl-. As seen in 85, where the squaramide motif was placed at the 
bottom of the naphthalimide fluorophore resulted in a higher affinity for Cl- 
compared to 87 where the squaramide motif was placed at the top of the 
naphthalimide fluorophore. A similar trend was also observed for the NO2 
substituted counterparts 86 and 88. On all occasions a good fit to a 1:1 binding 
isotherm was observed for receptor 85 as shown in Figure 2.27., with those of 86, 
87 and 88 shown in the Appendix while Figure 2.29 shows a combination of bind fit 
graph of the 1H NMR spectrum (chemical shift of Ha proton (ppm)) of 85, 86, 87 and 
88 with increasing Cl- equivalents in DMSO-d6.  
59 
 
 
Figure 2.29: (a):  Combination of bind fit graph of the 1H NMR spectrum (chemical 
shift of Ha proton (ppm)) of 85, 86, 87 and 88 (2.5 × 10-3 M, DMSO-d6) with 
increasing TBA chloride equivalents in a DMSO-d6 solution of 85 – 86. 
 
2.7 Conclusion and Future work 
In this Chapter, we have successfully developed four novel anion receptors 85 – 88. 
These novel receptors have been shown by 1H NMR analysis and SEM analysis to 
self-associate at room temperature and self-dissociate at higher temperatures (343 
K). According to the photophysical properties of receptors 85 – 88 in DMSO, 
receptor 85 and 87 have proved to be more emissive in DMSO solution compared 
to receptors 86 and 88 which are less emissive in DMSO solution. Furthermore, the 
addition of anions (AcO-, F-, PO4
3- and SO4
2-) as their TBA salts led to deprotonation 
events within receptors 85 – 88, this event was evident by UV/Vis titration, 
fluorescence titration and 1H NMR spectroscopic analysis. However the receptors 
were shown to be selective towards Cl- via classical H-bonding interaction between 
the binding site and Cl-, resulting in a subtle colour change. The position of the 
binding site (top or bottom) on the signalling unit was observed to play a major role 
in the affinity towards Cl- binding, these was ascribed to the number of H-bonding 
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available in the binding pocket. This was further by a good 1:1 binding isotherm 
observed for 85, 86, 87 and 88 with a Ka value of 488.62, 273.65, 221.26 and 114.80 
M-1 respectively. In conclusion, 85 is the most selective receptor towards Cl- binding 
with 88 being the least selective. 
Future perspectives of this work will look to further evaluate the SEM images of 
novel anion receptors 85 – 88, in order to further understand the unique 
morphologies of our novel receptors. 
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Chapter 3 - Squaramide Based Low Molecular Weight Gelators (LMWGs) 
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3.1 Introduction 
In recent years, the study of gels derived from low molecular weight gelators have 
gain immense attention due to their ability to serve as media for a range of 
applications.123-127 
This review Chapter will present a review of the areas of supramolecular gel, 
especially low molecular weight gelators (LMWGs), giving a brief introduction into 
the definition, formation, classification and characteristic of a gel. This Chapter will 
also elaborate on some key findings and more recent developments. 
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3.2 What is a Gel? 
Gels are stiff, flexible, soft, solid materials present in our everyday life. From 
commercial products such as shampoo, hair gel, toothpaste to other cosmetics, as 
well as soft contact lenses and lubricating grease (Figure 3.1).  
 
Figure 3.1: Examples of gels present in our everyday life. 
In general, gels have a solid-like appearance and do not flow, being predominantly 
liquid in composition. Gels have found applications in fields as diverse as food, 
cosmetics, materials science and petroleum industries, and have potential 
applications in lithography,128 catalysis129, 130 and drug delivery.131-135 Despite the 
fact that gels are common in nature and are frequently encountered in our 
everyday life, a precise definition was still unknown, until Flory in 1974.  
Flory defined a gel as a two component colloidal dispersion exhibiting a continuous 
microscopic structure with macroscopic dimensions, which is permanent on time 
scale of analytic experiments, and that is solid-like in its rheology behaviour below 
certain stress limit, despite of being mostly liquid.136 The colloidal dispersion causes 
an increase in the viscosity in the liquid medium by forming a matrix which entraps 
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the liquid. This allows the system to attain a semi-solid consistency in-between the 
liquid and solid state. However, not all gel systems are colloidal in nature, gels 
consist of a solid 3D matrix which is constructed by the crosslinking of polymeric 
strands of macro-molecules by physical or chemical forces, in the presence of bulk 
gas or liquid phases.137 The viscoelastic solid-like appearance of a gel is a result of 
the entrapment and adhesion of the bulk gas or liquid phase (solvent) in the surface 
area of the solid 3D elastic matrix of the gelator molecules through surface tension 
and capillary forces.138 The following section will give a brief introduction on how 
gels are formed. 
 
3.3 Gels Formation 
In analogy to proteins the fibrous network of gels can be divided into primary, 
secondary and tertiary structures (Figure 3.2).139-141 The primary structure 
(angstrom to nanometer scale) derives from the anisotropic aggregation of gelator 
molecules in 1D or 2D structures. The primary rod like aggregates is determined by 
molecular level recognition in which their characteristics depend on the influence of 
the ratio of cross-sectional areas of hydrocarbon chain, polarity of the solvent and 
the different moieties of the gelator.  
 
Figure 3.2: The primary, secondary and tertiary structures of a self-assembled urea 
based LMWG.141  
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Furthermore, these primary structures self-assemble to form aggregates (nano- to 
micro-meter scale) that may acquire several morphologies such as vesicles, sheets, 
micelles, ribbons or fibres, and is directly influenced by the molecular structure 
(Figure 3.2). Finally, the transition from secondary to tertiary (micro- to milli-meter 
scale) depends on the strength and type of interactions between the individual 
aggregates (Figure 3.2). However, the important factors affecting the gelation 
process includes the nature and polarity of the solvent, temperature and the 
molecular shape of gelator. The following section will give a brief introduction on 
how gels are classified based on their origin, constitution, the type of cross-linking 
that creates their 3D network. 
 
3.4 Classification of Gels 
Gels may be classified according to their origin, constitution, the type of cross-
linking that creates their 3D network and the solvent they are surrounded by 
(Figure 3.3). Regarding the solvent, gels may be formed in water (hydrogel), in an 
organic solvent (organogel) or in air (aero or xerogel). The non-covalent interactions 
required to promote gelation are dependent on the solvent. Gelation in organogels 
is mostly achieved by dipolar interactions such as H-bonding and metal 
coordination whereas gelation in hydrogels is often due to the solvophobic 
effect.142 Gels can be further subdivided into chemical gels and physical gels, 
depending on the strength and type of interactions that assist in self-assembly. In 
chemical gels, the formation the 3D network occurs via covalent crosslinking of its 
components which most cases usually results in the formation of crosslinked 
polymer gels. 
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Figure 3.3: Classification of gels.  
However, the self-assembly process of physical gels is promoted via non-covalent 
interactions such as van der Waals, dipole-dipole, π-π stacking, charge transfer, H-
bonding, and metal coordination interactions. The majority of the natural occurring 
gelators are macromolecular and they form gels by physical cross-linking usually via 
H-bonding.143 However, gels derived from synthetic compounds can be further 
subdivided depending on their constitution (macromolecular or molecular). 
Furthermore, gels formed by strong chemical bonds are thermally irreversible, 
whereas gels formed by weak non-covalent interactions are thermoreversible.144, 145 
With respect to this thesis, it is important to define supramolecular gels, which are 
nanostructured soft materials formed by anisotropic aggregation of low-molecular 
weight (LMW) molecules into 1D structures, that further self-assemble into 3D 
fibrillar networks that percolate the solvent and supramolecular polymer gels which 
are due to the physical aggregation of polymer chains.146, 147 The following section 
will give a brief insight into how a gel can be quantified and characterised using 
various techniques. 
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3.5 Characterisation of Gels 
The thermoreversibility of gels formed by the heating and cooling method allows 
for the identification of characteristic temperatures related to self-assembly and 
disassembly processes. The characteristic viscosity points of a gel, such as the 
temperature at which the gel is formed (Tgel) and the temperature at which the gel 
loses its structural integrity (Tsol) may be identified by visual inspection techniques 
such as bubble motion, dropping ball technique and the common inverted test tube 
method. The temperatures, Tgel and Tsol are dependent on the nature of the solvent, 
structure of the gel and the total concentration of the gelator. The minimum 
gelator concentration (m.g.c) which is defined as the minimum amount of gelator 
required to achieve the formation of a gel network capable of entrapping a specific 
solvent, may also be determined by the visual inspection techniques mentioned 
above. The m.g.c is the result of the concentration of the material required for the 
3D network formation (Cagg) and the concentration of gelator molecules that remain 
in solution (Csol). Csol may be determined by 
1H NMR spectroscopy, using a 
concentric tube with an internal reference of know concentration.148 
Furthermore, another important characteristic of a gel is related with its 
mechanical stability, which can be determined by rheology. Rheology is the study of 
deformation and flow of matter under the influence of applied stress. In rheological 
experiments, the gel is subjected to an oscillatory stress, and the response of the 
material is measured in terms of elastic storage modulus (G’, the contribution of 
the elastic) and elastic loss modulus (G’’, the contribution of the viscous). Rheology 
gives an insight on the relaxation and lifetime of the non-covalent bonds between 
gelator molecules. This allows the differentiation between hard gels (where, G’ >> 
G’’ at all frequencies) and soft gels (where, G’ > G’’ at high frequencies and G’< G’’ 
at low frequencies). The gel point, which is defined as the point at which G’ starts to 
exceed G’’, may also be determined by rheology.149, 150 Rheology studies may also 
be complemented with microscopy techniques such as scanning electron 
microscopy (SEM) or transmission electron microscopy (TEM) in order to relate the 
viscoelastic properties of the gel with the morphology of the fibre network. 
Crystallographic techniques such as small angle X-ray scattering (SAXS) and small 
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angle neutron scattering (SANS) may give an insight on the size, morphology and 
supramolecular arrangement of the fibres present in a gel.151 However, the use of 
SAXS and SANS is limited due to the presence of defects on the fibres and the 
difficulty of obtaining a crystal. Therefore, powder X-ray diffraction (XRD) of 
lyophilised gels is commonly used to obtain information on the structure of the gel 
and organisation of fibres. Fourier transform infrared (FTIR), Raman and NMR 
spectroscopy also provide information on the supramolecular arrangement of the 
gel via the study of H-bonding interactions. However, in the gel phase very broad 1H 
NMR signals are obtained due to the large correlation time of the assemblies and 
the very short transversal relaxation times (T2).
152 The next section will give a brief 
introduction on supramolecular gels and especially gels derived from low molecular 
weight gelators (LMWGs). 
 
3.6 Supramolecular Gels 
Low molecular weight gelators (LMWGs) are molecules with molar mass less than 
3000 Da and are capable of gelling in organic solvents (organogels) or in water 
(hydrogels). Although LMWGs discovered in the early nineteenth century,153 it is 
only recently that they have become a focused area of supramolecular chemistry. 
Organogels are formed by assembly of low molecular weight organogelators 
(LMWOGs) into entangled 3D networks through weak intermolecular forces such as 
H-bonding, van der Waals, metal coordination, π-π stacking, solvophobic forces and 
van der Waals interactions in which solvent molecules are efficiently entrapped and 
immobilised.154-157 However, these weak intermolecular forces can easily be 
manipulated by external stimuli such as pH,158 anions,159-161 redox agents,162 electric 
or magnetic fields,163, 164 light165, 166 and sound,167 which allows for the tuning of the 
physical properties of the gel. Gelation by LMWOGs is thermally reversible, a 
sample can be heated above and cooled below the gel transition temperature, Tgel 
(the sol ↔ gel transition temperature), many times to transform a gel into a sol and 
the back into a gel unless there is thermal decomposition. The general 
thermorevesibility of LMWOGs is one of the features that separate them from most 
polymer gelators.137, 144  
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Polymer based organogelator168 
Steed and co-workers
89
Low molecular weight fluoroscent organogel 169 
Prasad and co-workers
90
Cholesterol organogelator170 
Lee and co-workers
91
Platinum-steroid LMWOG171 
Tu and co-workers
92
 
Figure 3.4: Some examples of LMWOGs 1 - 4.168-171 
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LMWOGs which are able to gel organic liquids, generally do not display 
hydrogelling141 capability and vice-versa. LMWOGs have attracted growing 
attention particularly in the field of supramolecular chemistry.172 These recent  
attractions are due to the reversible nature of the interactions between the gelator 
molecules, the wide range of solvents that can be gelled and the possibility of 
adjusting the gel’s behaviour by introducing responsive or switching functionality 
either as part of the gelator itself or by an external chemical stimulus such as 
change in pH, or addition of molecules or ions that interact with the gel.173. In 
LMWOGs, directional H-bonding and dipolar interactions tend to dominate the gel 
self-assembly process. Compounds like amides and ureas are particularly effective 
LWMGs because of their ability to form a primary structure comprising infinite H-
bonded tapes in 1D while interacting laterally by much weaker bonds such as van 
der Waals interactions.174 LMWOGs as illustrated in (Figure 3.4) can be polymer 
based, metal based, synthetic cholesterol based, some organogels have also been 
reported to be fluorescent.168-171 
As discussed in chapter one, amide and urea units not only constitute ideal anion 
binding sites, but also act as useful motifs for supramolecular architectures via 
intra- or inter- molecular H-bonding and self-assembly interactions. The following 
section will give a range of examples of amide, urea and squaramide based LMWGs. 
 
3.7 Amide based LMWGs 
Amide N-H units are well known anion binding sites due to polarisation via 𝜋-
conjugation with the neighbouring carbonyl moiety. Webb and co-workers 
developed an alkyl-substitued pyromellite tetraamide based LMWOG 93 (Figure 
3.5) that gels non-polar organic solvents such as hexane, toluene, diethyl ether and 
cyclohexane due to the H-bonding interactions between the gelators.159 LMWOG 93 
binds to anions added as tetrabutylammonium (TBA) salts through conformation 
changes of its amide units in dilute solutions. The cyclohexane gel of 93 is 
transformed into a solution by the addition of 0.25 eq of TBA salts (Cl-, Br-, I-, AcO- 
and NO3
-). This is due to the weaker association between the gelator molecules 
which is caused by the interaction with the anion at the H-bonding N-H sites.159 
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Webb and co-workers reported that upon the addition of TBA salts as solid on the 
gel surface, the transformation from gel to solution takes from minutes to seconds, 
depending on the affinity of 93 to the anions salts (Cl- > AcO- > Br- > NO3
- > I-). 
However, inorganic salts such as NaI do not produce such a transition to the 
solution state.159 
 
93
 
 
 
Figure 3.5: (A) Structure of gelator 93 developed by Webb and co-workers.159 (B) X-
ray crystal structure of gelator 93 showing the formation of 1-D columnar stacks via 
intermolecular H-bonding network.159 
 
Džolić et al. studied the gelation properties of anthraquinone based oxalamide 
gelators 94 and 95 (Figure 3.6).175 Gelator 94 was reported to possess excellent 
gelation properties toward alcohols and aromatic solvents. However, gelator 95 
only affords precipitates and was incapable of forming gels with any of the tested 
solvents. This result suggests that the position of amide-substituents significantly 
(A) 
(B) 
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influences the gelation abilities.175 According to Džolić et al., molecular modelling 
showed that the minimised conformation of gelator 94 contains a strong 
intramolecular H-bond which is formed between the anthraquinone bound N-H and 
the vicinal anthraquinone carbonyl oxygen leading to planarization with the first 
oxalamide unit. However, such H-bonding was not achieved for gelator 95 which 
makes the N-H more available for H-bonding with PO4
3- and AcO- oxygens.175 
 
94
95  
Figure 3.6: Structure of gelator 94 and 95 studied by Džolić et al.175 
  
3.8 Urea Based LMWGs 
Ureas are attractive scaffolds for the design of LMWGs due to the urea α-tape motif 
which allows urea based LMWGs to undergo self-assembly (Figure 3.7).176  
 
H-bond acceptor
H-bond donor
 
Figure 3.7: (A) Hydrogen bond donor and acceptor abilities of urea. (B) Urea 
hydrogen bonding via the urea α-tape motif.176  
(A) (B) 
73 
 
This key supramolecular interaction that results from urea self–association to form 
a 6-membered hydrogen bonded ring based on two donors and one carbonyl 
acceptor has been used extensively in supramolecular self-assembly.177  
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Figure 3.8: (A) Structure of organogelator 96 developed by Steed and co-workers.178 
(B) X-ray crystal structure of gelator 96.178  
 
Steed et al. developed a chiral tris-urea organogelator 96 (Figure 3.8) that exhibits 
Cl- affinity in DMSO and gels aqueous DMSO and aqueous methanol.178 Addition of 
TBACl to the gel impedes the gelation process, decreases the amount of solvents 
included in the gel, and thus results in the formation of both gel and crystals.178 X-
ray crystallography analysis revealed that the crystals formed in the absence of Cl- 
salts comprised only the gelator molecules bound through intramolecular and 
intermolecular hydrogen bonding between the urea units.178  
 
97  
Figure 3.9: Structure of urea-substituted binaphthalene 97 based LMWG developed 
by Wang et al.179 
(A) (B)   
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Wang et al. synthesised a urea-substituted binaphthalene based LMWG 97 (Figure 
3.9), which gives transparent supramolecular gels from cyclohexane through H-
bonding and π-π stacking interaction.179 Upon the addition of one equivalent of 
TBAF, Wang et al. observed an interference of the H-bonding between the gelator 
molecules to afford a solution.179 However, no significant absorption spectral 
changes caused by F- binding have been observed as a result of the σ-bond 
connection between the H-bonding amide units and the chromophore binaphthyl 
unit. Yang et al. synthesised bis-urea functionalised naphthalene organogelators 98 
- 100 (Figure 3.10), which use cooperative H-bonding and π-π stacking interaction 
to form emissive supramolecular gels from various solvents156. 
 
98: R = C
6
H
13
 
99: R = C
12
H
25
100: R = C
16
H
33  
Figure 3.10: Structure of bis-urea functionalised naphthalene organogelators 98-
100 designed and developed by Yang et al.156 
 
The gel-sol transition of the system, as well as the fluorescent emission were both 
reported to be reversibly controlled by a change of temperature or upon the 
alternating addition of F- and H+. The gels are decomposed to solution by F- addition 
and are re-formed by H+ addition. However, the reformed gels exhibit emission 
behaviour and organised structures unlike those of the original gels. Yang et al. 
reported the influence of F- on the fluorescence and gel-sol processes to be due to 
the dissociation of intermolecular H-bonds by bonding of F- with the urea groups of 
the gelator.156 Yamanaka and co-workers developed a C3-symmetric tris-urea based 
gelator 101 (Figure 3.11) which is capable of forming opaque supramolecular gels 
from acetone by sonication.180 However, cooling the thermally dissolved acetone 
solution results in precipitation and no gel formation. Compound 101 gels in a 
variety of polar organic solvents such as THF, methanol and diethylphthalate but 
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forms no gels from non-polar solvents such as toluene, hexane and 
dichloromethane. 
101  
Figure 3.11: Structure a tris-urea based gelator 101 developed by Yamanaka and co-
workers.180 
 
According to IR measurements, H-bonding at the urea unit is reported to be a 
crucial factor for gel formation.180 This was also supported by the gelation 
behaviours of the derivatives lacking these interaction sites. Yamanaka and co-
workers, reported gel state recovery upon the addition of BF3
.OEt2 to the F
- 
mediated solution state.180 Acetone gel was also reported to transform to solution 
upon the addition of TBAF and TBACl. Furthermore, the addition of ZnBr2 to the 
solutions mediated by F-, Cl-, Br-, I- and AcO- also affords supramolecular gels.180  
In 2008, Steed et al. developed seven alkyl-bridged bisurea compounds of type 102 
(n = 2-8) (Figure 3.13), which form gels if the number of methylene units is even 
(n=2, 4, 6, 8) and no gels if odd (n= 3, 5, 7) from CH3CN, CHCl3, MeOH, toluene and 
solvents mixture such as DMSO/H2O and MeOH/H2O.
181 
 
n
102 (n = 2-8)  
Figure 3.12: Structure of gelator compounds 102 with n = 2-8.181 
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Figure 3.13: Crystal packing diagrams showing the urea tape motif of compounds 
102 with n = 2 (a), 4 (b), 5 (c).181 
 
This observation was reported to be correlated with the orientation of the urea 
units as interaction sites which is also confirmed justified via X-ray crystallography 
analysis.181 In 2013, Wu and co-workers designed an anthracene gelator 103 based 
on cyclic urea unit to produce molecular gels in various solvents (Figure 3.14).182 
Interestingly, the resulting gel 103/DMSO provides fascinating potential in TBAF 
discrimination via both colour and fluorescent alternation with high selectivity and 
sensitivity. The gel-to-sol transformation is reversible by the alternative addition of 
F- and methanol.182 
 
 
 
Figure 3.14: Structure of organogelator 103 developed by Wu and co-workers.182 
 
 
 
(a) (b) (c)  
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3.9 Squaramide Based LMWGs 
As seen in chapter 1, squaramides are four membered ring conjugated diamines 
derived from squaric acids, with the capacity for selectively binding to different H-
bond acceptors through their acidic N-H groups (Figure 1.16).110 Analogous to ureas 
as discussed in section 3.7, squaramides are interesting scaffolds for the design of 
LMWGs due to their enhanced hydrogen bond donor-acceptor ability (Figure 3.15). 
Disecondary squaramides and squaramic acids are extremely advantageous 
scaffolds for LMWGs assembly, because they can establish synergic H-
bonding/aromaticity relationships that control the outcome of the aggregation 
process.183 
 
 
Figure 3.15: (A) Urea hydrogen bonding via the urea α-tape motif. (B) Squaramide 
hydrogen bonding via the urea α-tape motif. 
 
However, despite the increasing number of squaramide based compounds in 
literature, the study of their self-assembly properties in solution for the synthesis of 
soft functional materials (gels) has remained mostly unexplored.184 Diaz et al. 
reported the self-assembly properties of squaramide based supramolecular 
(B) (A) 
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LMWOGs 104 - 113 (Figure 3.16).185 Compound 104 showed an unusual selectivity 
to form stable gels in a number of alcoholic solvents (alcogels), with the exception 
of acetone due to the keto-enol equilibrium of acetone. However, no gelation 
tendency was reported for compounds 105 - 113, which suggests the existence of 
unique molecular interactions and a hydrophobic/hydrophilic balance that supports 
the self-assembly of compound 104 in alcohols.185  
 
104
105  
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Figure 3.16: Structure of squaramide based supramolecular LMWOGs 104 - 113 
studied by Diaz et al.185 
 
According to UV-vis analysis of compound 104, the sol-to-gel transition did not 
show a shift of the absorption maximum, suggesting that the aggregation mode of 
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compound 104 in solution is similar to in the gel phase. Furthermore, the 
comparison of the FTIR spectrum of solid compound 104 with those of the xerogels 
and compound 104 in solution only revealed a slight alteration with small frequency 
shifts to lower wavelengths for characteristic peaks.185 Diaz et al. suggested that 
compound may also be aggregated in the solid state due to H-bonding and π-π 
stacking interactions which is also in agreement with the UV-vis measurements 
during the sol-to-gel transition. In contrast to the PXRD pattern of compound 104, 
non-gelators 105 - 113 showed additional peaks after 17 °C, especially compounds 
108 and 110 with extremely higher crystallinity than compound 104.185 The 
application of a heating ultrasound protocol instead of the heating-cooling cycle 
allows not only the formation of alcogels that could otherwise not be formed, but it 
also decreases both CGC and gelation times in comparison to the heating-cooling 
treatment.185 Moreover, Diaz et al. revealed that the nature of the solvent has a 
remarkable effect on the morphology of the aggregates and some gels also 
exemplify the strong competition between gelation and macroscopic crystallisation 
typically observed in weak physical gels.185 Furthermore, these alcogels were also 
reported to possess other interesting features such as thixotropic behaviour and 
phase selective gelation of non-miscible alcohol/water mixtures.185 
 
Recently, Costa et al. synthesised amphiphilic LMWHs 114 - 116 (Figure 3.17).186 
The addition of NaOH triggers the self-assembly and hydrogelation of 114 in 
minutes at a pH range of 3 - 9, with or without heating.186 Similarly, LMWH 115 also 
gels, but requires heating and the critical gelation concentration is higher.186 
However, after similar treatment, LMWH 116 remains as a suspension, even with 
excessive sonification and heating.186 Costa et al. reported the different 
morphologies observed in LMWG 114 - 116 and the failure of hydrogel formation of 
116 to be ascribed to the influence of peripheral substituents on the self-assembly 
of the precursor hydrogelators.186  
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Figure 3.17: Structure of amphiphilic squaramide based LMWHs 114 - 116 studied 
by Costa and co-workers.186 
To further explore the initial self-assembly events, Costa et al. studied the evolution 
of the 1H NMR spectra of solutions 114 in different solvent mixtures 
DMSOd6/H2O.
186 Upon increasing the amount of water in the solvent mixture, all 
aromatic protons were reported to exhibit significant upfield shifts, which indicate 
the growing influence of the aromatic stacking interactions that occur in water.186 
The HRMS spectra of 115 show an intense base signal at m/z 433.0789 assigned to 
the monomer anion with 44% contribution of the doubly charged dimer.186 The 
base signal of 115 appears at m/z 524.0681 and the contribution of the dimer 
increases to 60%.186 However, the molecular signal of 116 at m/z 389.3670 contains 
less than 3% of the dimer, which indicates the low aggregation ability of 3.186 
Finally, Costa and co-workers reported LMWH 114 to be thermoreversible, 
thixotropic, injectable, and can be loaded with a substantial amount of zwitterionic 
biomolecules, which are rarely used as payloads.186 
 
3.10 Conclusion 
This chapter gave a detailed insight on the definition, formation, classification, and 
characterisation of a gel. It also gave a brief introduction on the topic of 
supramolecular gels with some examples of current research on amide, urea and 
squaramide based LMWGs. The design and sythesis of our novel squaramide based 
LMWOGs will be discussed in the next chapter.
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Chapter 4 – Synthesis and Characterisation of Potential Novel Squaramide Based 
Low Molecular Weight Oragano-Gelators (LMWOGs) 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
82 
 
4.1 Introduction 
As discussed in Chapters one and two, urea and squaramides units not only 
constitute ideal anion binding sites, but also act as useful motifs for supramolecular 
architectures185, 186 via intra- or inter- molecular H-bonding and self-assembly 
interactions which the gelation processes of soft materials. Ureas are attractive 
scaffolds for the design of LMWGs due to the urea α-tape motif which allows urea 
based LMWGs to undergo self-assembly.176 This key supramolecular interaction 
that results from urea self–association to form a 6-membered hydrogen bonded 
ring based on two donors and one carbonyl acceptor has been used extensively in 
supramolecular self-assembly.177 
 
 
 
Figure 4.1: (A) Urea hydrogen bonding via the urea α-tape motif. (B) Squaramide 
hydrogen bonding via the urea α-tape motif. 
However, squaramides are more interesting scaffolds compared to their urea 
counterparts for the design of LMWGs due to their enhanced hydrogen bond 
donor-acceptor ability (Figure 4.1). Squaramides are extremely advantageous 
(A) (B) 
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scaffolds for LMWGs assembly, because they can establish synergistic H-
bonding/aromaticity relationships that control the outcome of the aggregation 
process183 and trigger self-assembly process which results in gel formation. 
Therefore, research on this project has centred on the development of novel di-
squaramide based low molecular weight organogelators (LMWOGs). In particular, 
we have focused on the development of novel LMWOGs based on three linker 
families.  
The overall aim of the work presented in this Chapter is to synthesise three families 
of novel LMWOGs based on their linker and a preliminary study of their gelation 
ability in a range of organic solvents. Firstly, a description of the design of each of 
the gelator family is given. This is followed by the synthesis and a discussion of the 
characterisation of each of the novel LMWOGs. Finally, a preliminary gelation test 
of all novel compounds was carried out in different solvents to determine the 
formation of novel LMWOGs. 
 
4.2 Design Requirements 
The design of the novel LMWOGs will be based on three different requirements 
which include; the linker, the squaramide motif and the variable R groups as 
outlined in Figure 4.2. 
 
Figure 4.2: Schematic representation of potential di-squaramide based low 
molecular weight organogelators (LMWOGs). 
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4.2.1  The Linker 
Three different linkers 117, 120 and 121 were exploited in the design of the novel 
LMWOGs as shown in Figure 4.3. The influence of linkers 117, 120 and 121 on the 
urea motif has been reported in the literature to trigger gel formation in organic 
solvents.168, 187 Linker 120 was introduced into the design of the novel compounds 
to promote potential stacking interactions via increased structural rigidity, which is 
ascribed to the reduced degrees of rotation by the presence of the four methyl 
groups. Linker 117 was introduced into the design of the novel compounds to act as 
comparison for linker 121 which is less prone to aromatic stacking. Linker 117 
triggers aromatic stacking which is disrupted by the ethyl groups on linker 121, 
creating a balance between the stacking interaction and potential gel formation 
which are key characteristics to promote gelation behaviour. 
117 120
121  
Figure 4.3: Structure of linkers exploited in the design of potential novel LMWOGs. 
4.2.2  The Squaramide Motif 
Squaramides have the capacity for selectively binding to different hydrogen bond 
acceptors via their acidic NH groups resulting in the formation of multiple and self-
complementary H-bonds.185 These interesting scaffolds can also pack with each 
other via 𝜋 – 𝜋 interaction between the cyclobutenedione rings due to the planarity 
and aromacity.188 In the design of our novel LMWOGs, we foresaw that the 𝜋 – 𝜋 
interaction between the cyclobutenedione rings the remarkable hydrogen bonding 
donor ability of the squaramide motif could be utilised (Figure 4.1). 
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4.2.3  The Variable R Groups 
The R groups were varied to provide a diverse set of structures that will display 
various supramolecular interactions. The design of the novel compounds as shown 
in Figure 4.4. Firstly, the ability of aliphatic alkyl R groups such as n-butylamine 125 
and decylamine 126 to increase solubility in organic solvents via Van der waals 
forces of interaction was incorporated into the design of the novel compounds. The 
introduction of aromatic ring such as in benzylamine 127 and 4-
hydroxybenzylamine 128 induces aromatic stacking with additional potential H-
bonding interaction through the phenol moiety in 128. The potential of developing 
metallogels was also investigated by incorporating 4-(aminomethyl)pyridine 129 
into the design of the novel compounds, with the potential of developing 
metallogel complexes via the nitrogen (N) atom in the pyridine ring of 129. The 
position of the N atom was varied to the 3-position 130 and the 2-position 131, to 
introduce a structural diversity in the design of novel compounds 146 – 148. 
129
126
128
130 131
127
125
 
Figure 4.4: Structure of the variable R groups exploited in the design of potential 
novel LMWOGs. 
With such structural diversity, we envisaged our design would give rise to a number 
of potential LMWG candidates. In the following chapter, the description of the 
synthesis and characterisation of each of the target novel compounds as outlined in 
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Figure 4.5 will be given. This will be followed by a summary of the gelation ability of 
each novel compound in polar aprotic, polar protic and non-polar solvents. 
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Figure 4.5: Structure of novel target compounds. 
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4.3 Synthesis  
The target compounds were prepared from commercially available starting 
materials. All target and intermediates compounds were fully characterised using 
1H NMR, 13C NMR, infrared spectroscopy and high resolution mass spectroscopy. 
4.3.1  Synthesis of Linker 89 Target Compounds 132 – 136. 
The synthesis of target compounds 132 - 136 were achieved using intermediate 122 
as outlined in Scheme 4.2, using 132 as a representative example.  
 
Scheme 4.1: Synthetic pathway to intermediate 122 (i) Zn(OTf)2, EtOH. 
 
 
Scheme 4.2: Synthetic pathway to 132 (i) Et3N, DMF. 
89 
 
Firstly, intermediate 122 was synthesised as outlined in Scheme 4.1, by stirring a 
solution of linker 117 in EtOH with a solution of diethyl squarate 74 and zinc triflate 
to ensure that 74 was electrophilic enough prior to nucleophilic attack by linker 117 
in EtOH. Isolation of the product yielded the desired product 122 as a tan 
amorphous solid in 93% yield.  
 
Scheme 4.3: Synthetic pathway to 135 (i) Et3N, DMF. 
 
Scheme 4.4: Synthetic pathway to 136 (i) Et3N, DMF. 
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Compound 132 was synthesised as outlined in Scheme 4.2, via the nucleophilic 
addition of intermediate 122 to 125 in Et3N and DMF to yield compound 132 as an 
off-white amorphous solid in 86% yield. The same procedure was applied to the 
synthesis of compounds 135 and 136 using reagent 128 and 129 respectively as 
outlined in Scheme 4.3 and Scheme 4.4 respectively. Compound 135 was obtained 
as a grey amorphous solid in 93% yield while compound 136 was obtained as beige 
amorphous solid in 92% yield. The synthesis of compounds 133 and 134 was 
attempted under the same reaction conditions as compound 132, 135 and 136 as 
outlined in Schemes 4.2, 4.3 and 4.4 respectively. Unfortunately, 1H NMR and 13C 
NMR analysis of compounds 133 and 134 could not be obtained due to the 
insoluble nature of the compounds in DMSO-d6. Novel compounds 132, 135 and 136 
were fully characterised by 1H NMR, 13C NMR, HRMS and IR spectroscopy. However, 
the 13C NMR analysis of compound 132 and 136 could not be obtained due to the 
insoluble nature of the compound. As a representative example the 1H NMR 
spectrum of compound 132 is shown in Figure 4.6. 
 
 
Figure 4.6: The 1H NMR spectrum of compound 132 (500.13 MHz, DMSO-d6). 
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According to Figure 4.6, nine signals can be seen in the 1H NMR spectrum of 
compound 132. A triplet can be seen up-field at 0.90 ppm for the six methyl 
protons (H1/1’) which is due to the shielding effect by the four methylene protons 
(H2/2’). A quartet can be seen at 1.34 ppm for the four methylene protons (H2/2’) 
while a triplet at 1.54 ppm was observed for the four methylene protons (H3/3’). A 
singlet was observed down field at 3.59 ppm for the four methylene protons (H4/4’) 
due to the de-shielding effect of the electron withdrawing nitrogen atom on the 
two NH protons (H8/8’). A singlet at 3.84 ppm was observed for the two methylene 
protons (H5) due to the de-shielding effect of the two phenyl rings. A doublet was 
observed at 7.18 ppm for the four aromatic protons (H6/6’) due to the shielding 
effect by the two methylene protons (H5). A broad signal was observed at 7.32 ppm 
for the four aromatic protons (H7/7’) due to the de-shielding effect of the electron 
withdrawing nitrogen atom on the two NH protons (H9/9’).  A broad signal at 7.58 
ppm was observed for the two NH protons (H8/8’) due to the shielding effect of the 
four methylene protons (H4/4’) and the de-shielding effect of the cyclobutenedione 
rings. Finally, a broad signal was observed further downfield at 9.55 ppm for the 
two NH protons (H9/9’) due to the de-shielding effect of both the phenyl and 
cyclobutenedione rings. Successful formation of compound 132 was also evident 
from accurate mass spectrometry, where 132 displayed a peak at 501.2515 
corresponding to the [M + H] ion (3.68 ppm). The 1H and 13C NMR spectra of 
compounds 135 and 136 are shown in the appendix section. All other compounds 
were similarly characterised as outlined above. 
4.3.2  Synthesis of Linker 103 Target Compounds 137 – 141 
The synthesis of target compounds 137 – 141 were achieved using intermediate 
123 as outlined in Scheme 4.6, using 105 as a representative example. Firstly, 119 
was synthesised as outlined in Scheme 4.5, by stirring a solution of 118 in MeOH. 
Removal of solvent under reduced pressure yielded compound 119 as a white 
amorphous solid in 95% yield. Linker 120 was synthesised by refluxing a solution of 
compound 119 containing KOH in n-BuOH as outlined in Scheme 4.5. Removal of 
solvent and extraction of crude product in THF, followed by drying over Na2SO4 
yielded linker 120 as a yellow oil in 96% yield. Intermediate 123 was synthesised 
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according to Scheme 4.5, by stirring a solution of linker 120 in Et3N and EtOH with a 
solution of diethyl squarate 74 in EtOH. Purification of crude product via column 
chromatography yielded compound intermediate 123 as a sticky yellow residue in 
74% yield. 
 
Scheme 4.5: Synthetic pathway to intermediate 123 (i) MeOH; (ii) KOH, n-BuOH, 
reflux; (iii) Et3N, EtOH. 
Finally, compound 137 was synthesised as outlined in Scheme 4.6, via the 
nucleophilic addition of intermediate 123 to 125 in Et3N and EtOH to yield 
compound 137 as an off-white amorphous solid in 93% yield. The same procedure 
was applied to the synthesis of compound 138 -141 using reagent 126 - 129 
respectively as outlined in Scheme 2.6. Isolation by suction filtration afforded the 
products 126, 127, 128 and 129 as off-white, white, beige and light yellow solids 
respectively in 79%, 76%, 84% and 96% yield. Novel compounds 137 - 141 were 
fully characterised by 1H NMR, 13C NMR, HRMS and IR spectroscopy. As a 
representative example the 1H NMR spectrum of compound 137 is shown in Figure 
4.7. 
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Scheme 4.6: Synthetic pathway to target compounds 137 – 141 incorporating linker 
120 (i) Et3N, EtOH. 
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According to Figure 4.7, eight signals can be seen in the 1H NMR spectrum of 
compound 137. A triplet can be seen up-field at 0.88 ppm for the six methyl 
protons (H1/1’) which is due to the shielding effect by the four methylene protons 
(H2/2’). A multiplet can be seen at 1.31 ppm for the four methylene protons (H2/2’) 
while a multiplet at 1.48 ppm was observed for the four methylene protons (H3/3’). 
A singlet was observed slightly down field at 1.73 ppm for the twelve methyl 
protons (H4/4’) due to the de-shielding effect of the aromatic phenyl ring. A quartet 
at 3.53 ppm was observed down-field for the four methylene protons (H5/5’) due 
to the de-shielding effect of the electron withdrawing nitrogen atom on the two NH 
protons (H7/7’). 
 
Figure 4.7: The 1H NMR spectrum of compound 137 (500.13 MHz, DMSO-d6). 
A multiplet was observed down-field at 7.32 ppm for the four aromatic protons 
(H6). A singlet was observed at 7.44 ppm for the two NH protons (H7/7’) due to the 
shielding effect by the four methylene protons (H5/5’). Finally, a singlet was 
observed further downfield at 7.81 ppm for the two NH protons (H8/8’) due to the 
de-shielding effect of both the phenyl and cyclobutenedione rings. Successful 
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formation of compound 137 was also evident from accurate mass spectrometry, 
where 137 displayed a peak at 495.2985 corresponding to the [M + H] ion (3.92 
ppm). The 1H and 13C NMR spectra of compounds 138 - 141 are shown in the 
appendix section. All other compounds were similarly characterised as outlined 
above. 
4.3.3  Synthesis of Linker 110 Target Compounds 142 - 148 
The synthesis of target compounds 142 - 148 were achieved using intermediate 124 
as outlined in Scheme 4.8, using 142 as a representative example. Firstly, 
intermediate 124 was synthesised according to Scheme 2.7, by refluxing a solution 
of linker 121 in Et3N and EtOH with a solution of diethyl squarate 74 in zinc triflate 
and EtOH. Purification of crude product via column chromatography yielded 
compound intermediate 124 as a yellow oil in 59% yield. 
 
Scheme 4.7: Synthetic pathway to intermediate 124  (i) Et3N, Zn(OTf)2, EtOH, reflux. 
Finally, compound 142 was synthesised as outlined in Scheme 2.8, via the 
nucleophilic addition of intermediates 124 to 125 in Et3N and EtOH to yield 
compound 142 as an off-white amorphous solid in 55% yield. The same procedure 
was applied to the synthesis of compound 143 – 148 using reagent 126 - 131 
respectively as outlined in Scheme 4.8. Isolation by suction filtration afforded the 
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products 143, 144, 145, 146, 147 and 148 as white, off-white, brown and beige 
solids in 33%, 59%, 27%, 68%, 66% and 61% yield respectively. 
 
Scheme 4.8: Synthetic pathway to target compounds 142 – 148 incorporating linker 
121 (i) Et3N, EtOH. 
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These novel compounds were fully characterised by 1H NMR, 13C NMR, HRMS and 
IR spectroscopy. The 1H NMR spectrum of compound 142 is shown in Figure 4.8. 
According to Figure 4.8, seven signals can be seen in the 1H NMR spectrum of 
compound 142. A multiplet was observed up-field at 1.16 ppm for the eighteen 
methyl protons (H1/1’, H5/H5’) and the twelve methylene protons (H2/2’, H3/3’, 
H4/H4’). A multiplet was observed slightly down-field at 3.30 ppm for the eight 
methylene protons (H6/H6’) due to the presence of the aromatic phenyl rings. A 
singlet at 3.90 ppm was also observed for the two methylene protons (H7) due to 
the de-shielding effect of the two aromatic phenyl rings. 
 
4.8: The 1H NMR spectrum of compound 142 (500.13 MHz, DMSO-d6). 
A singlet at 3.90 ppm was also observed for the two methylene protons (H7) due to 
the de-shielding effect of the two aromatic phenyl rings. A singlet can be seen at 
7.02 ppm for the four aromatic protons (H8/8’). A broad signal at 7.49 ppm was 
observed for the two NH protons (H9/9’) due to the shielding effect of the four 
methylene protons (H4/4’) and the de-shielding effect of the cyclobutenedione 
rings. Finally, a broad signal was observed further downfield at 8.68 ppm for the 
two NH protons (H10/10’) due to the de-shielding effect of both the phenyl and 
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cyclobutenedione rings. Successful formation of compound 142 was also evident 
from accurate mass spectrometry, where 142 displayed a peak at 613.3767 
corresponding to the [M + H] ion (3.07 ppm). The 1H and 13C NMR spectra of 
compounds 143 - 148 are shown in the appendix section. All other compounds 
were similarly characterised as outlined above. 
4.3.4  Summary of Synthesis of Target Compounds 
Three different linkers 117, 120 and 121 which have been reported in the literature 
to trigger gel formation in organic solvents were exploited in the design and 
synthesis of the target novel compounds. Linker 117 was introduced into the design 
of the novel compounds to act as comparison for linker 121 which is less prone to 
aromatic stacking. Meanwhile, the aromatic stacking interaction is disrupted by the 
ethyl groups on linker 121, creating a balance between the stacking interaction and 
potential gel formation which are key characteristics to promote gelation 
behaviour. Furthermore, the potential stacking interactions triggered by structural 
rigidity via the reduced degrees of rotation by the presence of the four methyl 
groups was exploited in the design and synthesis of the target novel compounds.  
The 𝜋 – 𝜋 interaction and hydrogen bond donor capacity of the squaramide motif 
via their acidic NH groups was exploited in potential formation of multiple and self-
complementary H-bonds which could be advantageous to the self-assembly and 
self-aggregation process of a gel.  
Finally, a diverse set of structures that will take advantage of various 
supramolecular interactions were developed by varying the R groups in the design 
and synthesis of the target squaramide compounds. The ability of aliphatic alkyl R 
groups to increase solubility in organic solvents via Van der waals forces of 
interaction was exploited into the design and synthesis of the target novel 
compounds. The aromatic stacking interaction of the phenyl ring and the potential 
H-bonding interaction of the phenol moiety were also explored in the design and 
synthesis of the target novel compounds. The potential of developing metallogels 
via the nitrogen (N) atom of the pyridine ring was also investigated. 
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In summary, we have successfully developed potential LMWOGs based on three 
different linker families 117, 120 and 121. However, the synthesis of compounds 
133 and 134 was unsuccessful due to the insoluble nature of the compounds in 
majority of organic solvents. The preliminary gelation test conducted for all novel 
compounds in different solvents will be discussed next. 
4.4  Preliminary Gelation Test of all Novel Compounds 
Organogels are classified according to the solvent they are surrounded by, in which 
they can be formed in organic solvents such as polar, protic, polar aprotic and non-
polar solvents. The non-covalent interactions required to promote gelation in 
organogels is dependent on the solvent, which is mostly achieved by dipolar 
interactions such as H-bonding. It has been observed that squaramides exhibit 
significantly higher H-bonding abilities110, 183 compared to their urea analogues156, 
176, 177, 181 and that this results in superior self-assembly interactions. With this in 
mind, preliminary gelation test of all novel compounds was carried out in different 
solvents which include non-polar, polar aprotic and polar protic solvents, to 
determine the formation of novel LMWOGs. 
 
 
Figure 4.9: Representative photographs of up-side down vials containing LMWOGs 
prepared via heating-ultrasound (H-C) and heating-cooling (H-U). (A) Gelator 137 in 
DMSO. (B) Gelator 138 in DMF. (C) Gelator 143 in EtOH (left) and in toluene (right). 
The preliminary gelation tests were performed by dissolving 10 mg of each novel 
compound in 0.5 ml of eight different solvents. This was achieved by sonification of 
each sample followed by heating via a heat gun and cooling at room temperature 
A B C 
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for 24 hours. A summary of the results obtained from the preliminary gelation test 
of all novel compounds in different solvents are detailed in Table 4.1. 
Table 4.1: Summary of the results obtained from the preliminary gelation test of all 
novel compounds in different solvents. 
 
Novel 
Compounds 
Organic Solvents 
Polar 
Protic 
Polar Aprotic Non-Polar 
EtOH DMSO MeCN DMF CHCl3 Toluene DCM Pet.Ether 
132 I PS I I I I I I 
135 I S I I I I I I 
136 I PS I I I I I I 
137 I S I OG I I I I 
138 I PG I OG I I I I 
139 I S I I I I I I 
140 I S I I I I I I 
141 I S I S I I I I 
142 I S I S I I I I 
143 OG PG I S PG TG PG I 
144 I S I S I I I I 
145 I S I S I I I I 
146 I S I S I I I I 
147 I S I S I I I I 
148 I S I S I I I I 
 
KEY 
I = Compounds that are insoluble in solvent, OG = Compounds that form opaque 
gels in solvent, TG = Compounds that form transparent gels in solvent, S =  
Compounds that are soluble in solvent, PG = Compounds that partially form gels in 
solvent, PS = Compounds that are partially soluble in solvent. 
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4.4.1 Summary of Preliminary Gelation Test Results of all Novel Compounds 
A summary of the preliminary gelation test results of all novel compounds will be 
discussed in this section. 
4.4.1.1 Compounds Containing Linker 117 
Linker 117 target novel compounds 132, 135 and 136 formed no gels in polar 
aprotic, polar protic,  and non-polar solvents due to their insolubility in all the 
tested solvents. However, compound 135 which is fully soluble in DMSO and 132 
and 136 which are partially soluble in DMSO, none of the linker 117 target 
compound formed a gel, despite their solubilty in DMSO.  
4.4.1.2 Compounds Containing Linker 120 
Linker 120 target compounds 137 – 141 are insoluble EtOH, MeCN and non-polar 
solvents. Compounds 139 and 140 also insoluble in DMF unlike 137 and 141 were 
both soluble in DMF. Whereas compound 137 formed an opaque gel in DMSO while 
compound 138 formed an opaque gel in DMF as shown in Figure 4.9 (A) and (B) 
respectively. However, compounds 138 – 141 are soluble in DMSO, with 138 
forming a partial gel in DMSO.  
4.4.1.3 Compounds Containing Linker 121 
Furthermore, linker 121 target compounds 142, 144, 145, 146, 147 and 148 are 
insoluble in EtOH, MeCN and non-polar solvents with solubility in DMSO and DMF. 
Whereas compound 143 was insoluble in MeCN and petroleum ether with solublity 
in DMF. Compound 143 formed a partial gel in CHCl3, DMSO and DCM. Compound 
143 also formed an opaque gel in EtOH and a transparent gel in toluene as shown in 
Figure 4.9 (C) 
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4.5 Conclusion and Future work 
In this Chapter, we have successfully developed an array of potential novel 
LMWOGs. In particular, novel LMWOGs 137 which forms opaque gels in DMSO, 
while 138 forms opaque gels in DMF. Whereas, 143 forms opaque gels in EtOH and 
transparent gels in toluene. In summary, compound derived from linker 117 are 
insoluble in most of all the tested organic solvent except in DMSO. This was 
ascribed to the formation of aromatic stacking between their molecules. 
Nevertheless, improved solubility in polar aprotic solvents such as DMSO and DMF 
was observed for compounds derived from linker 120. However, compound 137 
gels in DMSO and whereas the formation of a gel of gelator 138 was evident in 
DMF. This behaviour was ascribed to the presence of the butyl and decylamine R 
group in compound 137 and 138 respectively, to enhance the solubility in organic 
solvents and the presence of linker 120 to improve structural rigidity and potential 
stacking interactions.  Furthermore, enhanced solubility in polar aprotic solvents 
such as DMSO and DMF was also observed for compounds derived from linker 121. 
Partial gelation of compound 143 was observed in DMSO, DCM and CHCl3 whereas 
the formation of an opaque gel was observed in EtOH while formation of a 
transparent gel was evident in toluene. This behaviour was also ascribed to the 
presence of the decylamine R group to increase the solubility in organic solvents 
and the presence of linker 121 to disrupt stacking interaction via the ethyl group 
and induces a balance between the stacking interaction and potential gel 
formation.  
Future perspectives of this work will look to further investigate the gelation studies 
of novel LMWOGs 137, 138 and 143, in order to further understand their gelation 
properties. The metallo-gellation capabilities of compounds 146 – 147 will also be 
investigated. This will be carried out by our collaborators, the Steed Research 
Group at Durham University. From our understanding of this chapter, we will 
investigate the design, synthesis and gelation properties of the target compounds 
149 – 153 based on using linker 124. Futhermore, we will also investigate the 
impact of increasing the ethyl chain on linker 124 to a propyl chain and the effect of 
103 
 
incorporating a thio-squaramide motif versus having a squaramide motif (Figure 
4.10). 
 
Figure 4.10: Future target compounds. 
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Chapter 5 – Conclusion 
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5.1 Conclusion 
The work carried out in this thesis was undertaken with a goal of the preparation 
and study of novel squaramide based materials for sensors and soft materials. The 
design, synthesis and photophysical as well as anion binding properties of a set of 
novel squaramide based anion receptors 85 – 88 were described in Chapter 2. 
Whereas, the design, synthesis and preliminary gelation test of potential gelators 
were discussed in Chapter 4. 
In Chapter 2, the novel receptors 85 – 88 were shown by 1H NMR analysis 
and SEM analysis to self-associate at room temperature and self-dissociate at 
higher temperatures (343 K). According to the photophysical properties of 
receptors 85 – 88 in DMSO, receptor 85 and 87 have proved to be more emissive in 
DMSO solution compared to receptors 86 and 88 which are less emissive in DMSO 
solution. Furthermore, the addition of anions (AcO-, F-, PO4
3- and SO4
2-) as their TBA 
salts led to deprotonation events within receptors 85 – 88, this event was evident 
by UV/Vis titration, fluorescence titration and 1H NMR spectroscopic analysis. 
However, the receptors were shown to be selective towards Cl- via classical H-
bonding interaction between the binding site and Cl-, resulting in a subtle colour 
change. The position of the binding site (top or bottom) on the signalling unit was 
observed to play a major role in the affinity towards Cl- binding, this was ascribed to 
the number of H-bonding available in the binding pocket. This was further 
supported by a 1:1 binding isotherm observed for 85, 86, 87 and 88 in DMSO with a 
Ka value of 488.62, 273.65, 221.26 and 114.80 M
-1 respectively. In conclusion, 85 is 
the most selective receptor towards Cl- binding with 88 being the least selective. 
Future perspectives of this work will look to further evaluate the SEM images of 
novel anion receptors 85 – 88, in order to further understand the unique 
morphologies of our novel receptors. 
In Chapter 4, we successfully developed an array of potential novel 
LMWOGs and studied their gelation ability in a range of solvents. In particular, 
novel LMWOGs 137 which forms opaque gels in DMSO and 138 which forms 
opaque gels in DMF. This behaviour was ascribed to the presence of the butyl and 
decylamine R group in compounds 137 and 138 respectively, enhancing their 
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solubility in organic solvents and the presence of linker 120 to improve structural 
rigidity and potential stacking interactions. Furthermore, gelator 143 forms opaque 
gels in EtOH and transparent gels in toluene. This behaviour was also ascribed to 
the ability of the decylamine R group to increase the solubility in organic solvents 
and the presence of linker 121 to disrupt stacking interaction via the ethyl group 
and induces a balance between the stacking interaction and potential gel 
formation. Future perspectives of this work will look to further investigate the 
gelation studies of novel LMWOGs 137, 138 and 143, in order to further understand 
their gelation properties. The metallo-gellation capabilities of compounds 146 – 148 
will also be investigated. This will be carried out by our collaborators, the Steed 
Research Group at Durham University. From our understanding of this chapter, we 
will investigate the design, synthesis and gelation properties of the target 
compounds 149 – 153 based on using linker 124. Futhermore, we will also 
investigate the impact of increasing the ethyl chain on linker 124 to a propyl chain 
and the effect of incorporating a thio-squaramide motif versus having a squaramide 
motif (Figure 4.10). 
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Chapter 6 – Experimental 
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6.1 Instrumentation and Reagents 
Commercial materials were supplied by TCI Europe or Sigma Aldrich and were used 
without further purification. HPLC grade solvents were used as received. 1H NMR 
spectra were recorded using a Bruker Avance III 500 at a frequency of 500.13 MHz, 
and are reported as parts per million (ppm) with CDCl3 (δH 7.26 ppm) or DMSO-d6 
(δH 2.50 ppm) as an internal reference. The data are reported as chemical shift (δ), 
multiplicity (br = broad, s = singlet, d = doublet, t = triplet, m = multiplet), coupling 
constant (J, Hz) and relative integral. 13C NMR spectra were recorded using a Bruker 
Avance III 500 at a frequency of 125.76 MHz and are reported as parts per million 
(ppm) with CDCl3 (δH 77.1 ppm) or DMSO-d6 (δH 39.5 ppm) as an internal 
reference. High resolution ESI spectra were recorded on an Agilent 6310 LCMS TOF. 
Analytical TLC was performed using pre-coated silica gel plates (Merck Kieselgel 60 
F254). Flash chromatography was performed using silica gel 40-63 µM, 60 Å. 
Infrared absorption spectra were recorded on a Perkin Elmer Spectrum 100 FT-IR 
spectrometer using KBr disks. FT-IR are reported in wavenumbers (cm-1). 
Commercial materials were supplied by TCI Europe or Sigma Aldrich and were used 
without further purification, unless otherwise noted. Diethyl squarate were 
synthesised as previously described.189  
 
6.2 Spectroscopic Binding Studies 
Spectroscopic titrations were performed by additions of aliquots of the putative 
anionic guest (AcO-, Cl-, F-, PO4
3-, SO4
2-) as the tetrabutylammonium (TBA) salt 
solutions (20 mM made up in 1.199 × 10-5 M solutions of the receptors in DMSO) to 
a 1.199 × 10-5 M solution of the receptor in DMSO. Typically, up to 70 equivalents of 
the salts were added. After each addition, the resulting solution was stirred for at 
least 30 seconds and the absorbance was recorded. Both salt and receptor were 
dried under high vacuum prior to use. UV-Vis data was recorded using a Varian Cary 
50 UV-Vis Spectrophotometer. The absorbance was recorded from 250 nm to 850 
nm. To determine association constants for the receptor-anion complexes, global 
analysis of the absorbance data was carried out using the open access BindFit 
software program. Fluorescence titrations were carried out in parallel with the 
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UV/Vis absorption measurements using a Jasco FP-6300 spectrofluorometer. An 
example of a typical UV titration experimental layout is outlined in Table 6.1. 
 
Table 6.1: An example of a typical UV titration experimental layout  
 
Sample Number 
 
 
Total Volume of 
anion added (µL) 
 
Sample anion 
concentration (M) 
 
Molar ratio 
Receptor:Anion 
 
1 0.0 0.00E+00 1 : 0 
2 1.8 1.20E-05 1 : 1 
3 3.6 2.40E-05 1 : 2 
4 5.4 3.59E-05 1 : 3 
5 7.2 4.78E-05 1 : 4 
6 9.0 5.98E-05 1 : 5 
7 10.8 7.17E-05 1 : 6 
8 12.6 8.36E-05 1 : 7 
9 14.4 9.55E-05 1 : 8 
10 16.2 1.07E-04 1 : 9 
11 18.0 1.19E-04 1 : 10 
12 27.0 1.78E-04 1 : 15 
13 36.0 2.37E-04 1 : 20 
14 54.0 3.53E-04 1 : 30 
15 71.9 4.68E-04 1 : 40 
16 89.9 5.82E-04 1 : 49 
17 107.9 6.94E-04 1 : 58 
Note: 3000 µL of the stock receptor solution always present, and the anion aliquots 
are drawn from a 20 mM sample.  
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6.3 NMR Binding Studies   
NMR titrations were performed by additions of aliquots of the putative anionic 
guest (AcO-, Cl-, F-, PO4
3-, SO4
2-) as the TBA salt solutions (200 mM made up in 2.5 × 
10-3 M solutions of the receptors in DMSO-d6) to a 2.5 × 10
-3 M solution of the 
receptor in DMSO-d6. Typically, up to 20 equivalents of the salts were added. Both 
salt and receptor were dried under high vacuum prior to use. 1H NMR spectra were 
recorded on a Bruker Avance III 500 spectrometer at a frequency of 500.13 MHz 
and calibrated to the residual protio solvent peak in DMSO-d6 (δ = 2.50 ppm). Stack 
plots were made using TopSpin 3.2. An example of a typical experimental layout is 
outlined in Table 6.2. 
 
6.4 1H NMR Binding Studies of Novel Receptors 
Procedure: A 2.5 mM stock solution of receptor was accurately prepared in the 
stated deuterated solvents (v/v) using a pipette (Eppendorf). Solutions of anions to 
be titrated were prepared in separate 3 ml Eppendorf vials and 200μL deuterated 
solvents (v/v) were added using pipettes. In each case, the host solution in an NMR 
tube was titrated with aliquots of anion stock solution and after each addition, and 
the 1H NMR spectrum was recorded after thorough mixing at 300 K. Titrations were 
performed in triplicate to give accurate values. Typically a total of at least 20 
equivalents of anion were added. Non-linear curve fitting of the experimentally 
obtained titration isotherms (equivalents of anion versus chemical shift of NH, 
aromatic CH and methylene CH protons) using the program TopSpin 3.2 and 
Microsoft excel 2010, enabled the calculation of association constants (Ka/M-1) 
using the open access BindFit software program.120 
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Table 6.2: An example of a typical NMR titration experimental layout  
 
Sample Number 
 
Total Volume of 
Anion added (µL) 
 
Sample Anion 
Concentration (M) 
 
Molar Ratio 
Receptor:Anion 
 
1 0.0 0.00E+00 5 : 0 
2 1.3 4.99E-04 5 : 1 
3 2.6 9.95E-04 5 : 2 
4 3.9 1.49E-03 5 : 3 
5 5.2 1.98E-03 5 : 4 
6 6.5 2.47E-03 1 : 1 
7 7.8 2.96E-03 5 : 6 
8 9.1 3.44E-03 5 : 7 
9 10.4 3.92E-03 5 : 8 
10 11.7 4.40E-03 5 : 9 
11 13.0 4.88E-03 1 : 2 
12 20.0 7.51E-03 1 : 3 
13 27.0 1.01E-02 1 : 4 
14 41.5 1.52E-02 1 : 6 
15 56.0 2.00E-02 1 : 8 
16 70.5 2.46E-02 1 : 10 
17 85.0 2.89E-02 1 : 12 
18 100.0 3.86E-02 1 : 16 
19 138.0 4.97E-02 1 : 20 
Note: 500 µL of the stock receptor solution always present, and the anion aliquots 
are drawn from a 200 mM sample. 
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6.5 Synthesis and Characterisation of Compounds Described in Chapter 2 
3,4-Diethoxycyclobut-3-ene-1,2-dione (74)189  
 
In a 250 mL round bottomed flask, squaric acid (5.00 g, 43.84 mmol, 1 eq) was 
dissolved in EtOH (50 mL), triethyl orthoformate (19.97 mL, 120.12 mmol, 2.74 eq) 
was added to the reaction mixture drop wise and the reaction mixture was heated 
under reflux for 24 hours. The reaction was monitored by TLC and was and 
concentrated on a rotary evaporator. The residue was purified by column 
chromatography (silica gel, DCM) to yield a clear yellow liquid (yield: 6.363 g, 85%). 
1H NMR, (CDCl3, 500.13 MHz) δ (ppm), J (Hz): 1.06 (t, J = 7.1, 3H, CH3), 4.67 (q, J = 
7.1, 2H, CH2); 
13C NMR (CDCl3, 125.76 MHz): δ (ppm): 15.54, 70.51, 184.81, 189.23; 
HRMS (ESI) calcd. for C8H11O4 [M + H]
+ 171.0652, found 171.0646; difference -3.50 
ppm. 
3-((3,5-Bis(trifluoromethyl)phenyl)amino)-4-ethoxycyclobut-3-ene-1,2-dione (75) 
 
A solution of 3,5-bis(trifluoromethyl)aniline (1.835 mL, 11.75 mmol, 1eq) in EtOH (5 
mL) was slowly added to a mixture of 74 (1.74 mL, 11.75 mmol, 1 eq) and zinc 
triflate (0.85 g, 2.35 mmol, 0.2 eq) in 5 mL EtOH. The reaction was stirred at room 
temperature overnight. The precipitate was collected by suction filtration and 
washed with EtOH and Et2O to yield the product as an off-white amorphous solid. 
(3.28 g, 79%). 1H NMR, (DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.41 (t, J = 7.1, 3H, 
CH3), 4.79 (q, J = 7.1, 2H, CH2), 7.78 (s, 1H, ArH), 8.03 (s, 2H, ArH), 11.19 (br, 1H, 
NH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 184.9, 179.7, 140.6, 131.7, 131.4, 
131.2, 126.8, 124.6, 122.4, 119.9, 116.8, 70.5, 15.8; HRMS (ESI) calcd. for  
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C14H10F6NO3 [M + H]
+ 354.0559, found 354.0554; difference -1.64 ppm; νmax 
(KBr)/cm-1: 3254 (N-H), 3004 (ArH), 1717 (C=O), 1603 (ArH), 1278 (C-F), 1101 (C-O). 
3-Ethoxy-4-((4-nitrophenyl)amino)cyclobut-3-ene-1,2-dione (76) 
 
A solution of 4-nitroaniline (1.63 g, 11.75 mmol, 1 eq) in EtOH (5mL) was slowly 
added to a mixture of diethyl squarate (1.74 mL, 11.75 mmol, 1 eq) and zinc triflate 
(0.85 g, 2.35 mmol, 0.2 eq) in EtOH (5 mL). The reaction was stirred at room 
temperature overnight. The precipitate was collected by suction filtration and 
washed with EtOH and Et2O to yield the product as an orange amorphous solid 
(2.901 g, 94%). 1H NMR, (DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.44 (t, J = 7.1, 3H, 
CH3), 4.80 (q, J = 7.1, 2H, CH2), 7.59 (d, J = 9.0, 2H, ArH), 8.24 (d, J = 9.0, 2H, ArH), 
11.22 (s, 1H, NH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 16.06, 70.66, 119.51, 
125.75, 126.87, 142.97, 169.90, 185.25; HRMS (ESI) calcd. for C12H10N2NaO5 [M + 
Na]+ 285.0482, found 285.0496; difference 4.84 ppm; νmax (KBr)/cm
-1: 3304 (N-H), 
3083 (ArH), 1715 (C=O), 1623 (ArH), 1531 (N-O), 1114 (C-O). 
6-Bromo-2-ethyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (78) 
 
77, (2.0 g, 7.33 mmol, 1 eq) was mixed with ethylamine (0.57 mL, 8.66 mmol, 1.2 
eq) in EtOH (10 mL). The reaction mixture was heated under reflux for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a light tan amorphous solid. (1.74 g, 79%). 1H NMR, (DMSO-
d6, 500.13 MHz) δ (ppm), J (Hz): 1.21 (t, J = 7.0, 3H, CH3), 4.06 (q, J = 7.0, 2H, CH2), 
7.99 (t, J = 8.0, 1H, ArH), 8.21 (d, J = 7.8, 1H, ArH), 8.32 (d, J = 7.8, 1H, ArH), 8.55 (m, 
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ArH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 163.1, 163.1, 133.0, 132.0, 131.8, 
131.4, 130.3, 129.5, 129.3, 128.8, 123.3, 122.5, 35.4, 13.5; HRMS (ESI) calcd. for 
C14H11BrNO2 [M + H]
+ 303.9968, found 303.9964; difference -1.11 ppm; νmax 
(KBr)/cm-1: 3086 (ArH), 1740 (C=O), 1456 (ArH), 1354 (C-H), 1325 (C-N), 562 (Br). 
6-((2-Aminoethyl)amino)-2-ethyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (79) 
 
78, (1 g , 3.288 mmol, 1 eq) was stirred at room temperature overnight in neat 
ethylenediamine (10 mL, excess) to yield a dark orange liquid. The crude product 
was slowly added to deionised water (50 mL) and left to stir at room temperature 
for 2 hours. The precipitate was collected by suction filtration and washed with H2O 
to yield the product as a yellow amorphous solid. (0.748 g, 80%). 1H NMR, (DMSO-
d6, 500.13 MHz) δ (ppm), J (Hz): 1.11 (t, J = 7.0, 3H, CH3), 2.82 (t, J = 6.4, 2H, CH2), 
3.32 (t, J = 6.4, 2H, CH2), 3.97 (q, J = 7.1, 2H, CH2), 6.73 (d, J = 8.5, 1H, ArH), 7.60 (m, 
1H, ArH), 8.18 (d, J = 8.5, 1H, ArH), 8.36 (dd, J = 7.3, J = 0.9, 1H, ArH), 8.63 (dd, J = 
8.4, J = 0.8, 1H, ArH); 13C NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 13.7, 34.7, 46.7, 
104.3, 108.1, 120.6, 122.3, 124.6, 129.0, 129.8, 131.0, 134.6, 151.3, 163.1, 164.0; 
HRMS (ESI) calcd. for C16H18N3O2 [M + H]
+ 284.1394, found 284.1389; difference -
1.65 ppm; νmax (KBr)/cm
-1: 3358 (N-H), 2979 (ArH), 1676 (C=O), 1461 (ArH), 1370 (C-
H), 1249 (C-N). 
Tert-butyl(2-aminoethyl)carbamate (81)190 
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To a 500mL round bottom flask was added ethylenediamine (13.4 mL, 161.86 
mmol, 10 eq) in CHCl3 (100 mL). A solution of di-tert-butyl dicarbonate (4.4 g, 37.56 
mmol, 1 eq) in CHCl3 (50 mL) was added dropwise over 2 hours at 0°C and stirred at 
room for 24 hours. The reaction mixture was washed with brine, the organic layer 
was washed with H2O and dried over MgSO4. The filtrate was concentrated in vacuo 
to yield an off-white liquid. (2.012 g, 34%). 1H NMR, (DMSO-d6, 500.13 MHz) δ 
(ppm), J (Hz): 1.36 (s, 9H, CH3), 2.51 (d, J = 6.5, 2H, CH2), 2.90 (d, J = 5.8, 2H, CH2), 
6.71 (s, 1H, NH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 28.7, 31.7, 42.0, 44.1, 
77.8, 79.6, 156.1. 
Tert-butyl(2-(6-nitro-1,3-dioxo-1H-benzo[de]isoquinolin-2(3H)-yl)ethyl)carbamate 
(82) 
 
81, (0.565 mL, 3.54 mmol, 1 eq) was slowly added dropwise to a solution of 80, 
(0.86 g, 3.54 mmol, 1 eq) in EtOH (20 mL). The reaction mixture was left to react in 
a 35 mL microwave tube for 1 hour at 110 °C, 1 mbar and 300 watts. The precipitate 
was collected by suction filtration and washed with EtOH and Et2O to yield the 
product as a peach amorphous solid. (1.047 g, 76%). 1H NMR, (DMSO-d6, 500.13 
MHz) δ (ppm), J (Hz): 1.22 (s, 9H, CH3), 3.27 (t, J = 6.0, 2H, CH2), 4.14 (t, J = 6.0, 2H, 
CH2), 6.88 (s, 1H, NH), 8.09 (t, J = 8.1, 1H, ArH), 8.55 (d, J = 8.0, 1H, , ArH), 8.62 (m, 
2H, , ArH), 8.71 (d, J = 8.4, 1H, , ArH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 
28.5, 38.0, 77.9, 123.1, 123.5, 124.6, 127.3, 128.9, 129.0, 129.9, 130.5, 132.0, 149.5, 
156.2, 162.8, 163.6; HRMS (ESI) calcd. for C38H38N6NaO12 [2M + Na]
+ 794.2471, 
found 794.2493; difference 2.8 ppm; νmax (KBr)/cm
-1: 3401 (N-H), 2977 (ArH), 1714 
(C=O), 1593 (ArH), 1523 (N-O), 1365 (C-H), 1192 (C-N). 
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2-(2-Aminoethyl)-6-nitro-1H-benzo[de]isoquinoline-1,3(2H)-dione (83) 
 
82, (1.02 g, 2.647 mmol, 1 eq) was dissolved in (TFA : DCM, 50 : 50) (6 mL) and was 
stirred at room temperature overnight. The solvent was removed under reduced 
pressure to yield a beige amorphous solid. (0.70 g, 93%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 3.17 (m, 2H, CH2), 4.33 (t, J = 5.6, 2H, CH2), 7.81 (br, 
2H, NH2), 8.13 (m, 1H, ArH), 8.58 (d, J = 7.9, 1H, ArH), 8.66 (m, 2H, ArH), 8.76 (dd, J = 
8.69, J = 0.8, 1H, ArH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 37.9, 38.2, 123.2, 
123.4, 124.7, 127.2, 128.9, 129.4, 130.1, 130.6, 132.2, 149.7, 163.3, 164.0; HRMS 
(ESI) calcd. for C14H12N3O4 [M + H]
+ 286.0822, found 286.0800; difference -7.88 
ppm; νmax (KBr)/cm
-1: 3078 (ArH), 1712 (C=O), 1595 (ArH), 1525 (N-O),  1437 (C-H), 
1247 (C-N). 
6-Amino-2-(2-aminoethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (84) 
 
Pd/C (approx. 0.2 g) was added to a solution of 83, (1.00 g, 3.50 mmol) dissolved in 
MeOH (40 mL). The reaction was placed under a H2 atmosphere and left to stir at 
room temperature for 3 hours. The reaction was filtered through a pad of celite and 
washed with excess MeOH, the filtrate was removed under reduced pressure to 
yield a mustard amorphous solid. (0.673 g, 75%). 1H NMR, (DMSO-d6, 500.13 MHz) 
δ (ppm), J (Hz): 3.12 (m, 2H, CH2), 4.27 (t, J = 6.0, 2H, CH2), 6.86 (d, J = 8.4, 1H, ArH), 
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7.48 (s, 2H, NH2), 7.67 (m, 1H, ArH),  7.77 (br, 2H, NH2), 8.21 (d, J = 8.4, 1H, ArH), 
8.44 (dd, J = 7.3, J = 1.05, 1H, ArH), 8.63 (dd, J = 8.4, J = 1.1, 1H, ArH); 13C NMR, 
(DMSO-d6, 125.76 MHz) δ (ppm): 37.6, 38.4, 108.0, 108.6, 119.8, 122.4, 124.4, 
129.9, 130.4, 131.5, 134.5, 153.3, 163.9, 164.9; HRMS (ESI) calcd. for C14H13N3NaO2 
[M + Na]+ 279.0930, found 279.0914; difference -5.68 ppm; νmax (KBr)/cm
-1: 3419 
(N-H), 3362 (N-H), 3017 (ArH), 1636 (NH), 1485 (ArH), 1429 (C-H), 1247 (C-N). 
6-((2-((2-((3,5-bis(trifluoromethyl)phenyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)ethyl)amino)-2-ethyl-1H-benzo[de]isoquinoline-1,3(2H)-dione (85) 
 
A solution of 75, (0.436 g, 1.235 mmol, 1 eq) in EtOH (8 mL) was slowly added to a 
mixture of 79, (0.35 g, 1.235 mmol, 1 eq) and Et3N (0.689 mL, 4.94 mmol, 4 eq) in 
EtOH (12 mL). The reaction mixture was stirred at room temperature overnight. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as a yellow amorphous solid. (0.575 g, 78%). 1H NMR at 343K, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.18 (t, J = 7.0, 3H, CH3), 3.70 (q, J = 5.5, 2H, 
CH2), 3.95 (t, J = 5.5, 2H, CH2), 4.04 (q, J = 7.0, 2H, CH2), 6.91 (d, J = 8.5, 1H, ArH), 
7.47 (s, 1H, ArH), 7.63 (m, 2H, ArH), 7.80 (br, 2H, NH), 7.89 (s, 1H, ArH), 8.25 (d, J = 
8.5, 1H, ArH), 8.39 (d, J = 7.0, 1H, ArH), 8.58 (d, J = 8.3, 1H, ArH), 9.68 (br, 1H, NH); 
13C NMR at 343K, (DMSO-d6, 125.76 MHz) δ (ppm): 13.6, 30.9, 34.6, 43.2, 44.2, 
104.6, 109.1, 114.7, 118.3, 120.8, 122.5, 124.7, 128.6, 129.8, 130.9, 134.2, 141.5, 
150.7, 163.1, 163.9, 171.2, 181.3; HRMS (ESI) calcd. for C28H21F6N4O4 [M + H]
+ 
591.1462 found 591.1439; difference -3.8 ppm;  νmax (KBr)/cm
-1: 3292 (N-H), 3086 
(ArH), 2982 (C-H), 1796 (C=O), 1459 (C-H), 1278 (C-F), 1249 (C-N). 
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2-Ethyl-6-((2-((2-((4-nitrophenyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)ethyl)amino)-1H-benzo[de]isoquinoline-1,3(2H)-dione (86) 
 
A solution of 76, (0.324 g, 1.235 mmol, 1 eq) in EtOH (8 mL) was slowly added to a 
mixture of 79, (0.35 g, 1.235 mmol, 1 eq) and Et3N (0.689 mL, 4.94 mMol, 4 eq) in 
EtOH (12 mL). The reaction was stirred at room temperature. The precipitate was 
collected by suction filtration and washed with EtOH and Et2O to yield the product 
as an orange amorphous solid. (0.453 g, 73%). 1H NMR at 343K, (DMSO-d6, 500.13 
MHz) δ (ppm), J (Hz): 1.18 (t, J = 7.1, 3H, CH3), 3.70 (q, J = 6.0, 2H, CH2), 3.96 (t, J = 
6.0, 2H, CH2), 4.03 (q, J = 7.0, 2H, CH2), 6.91 (d, J = 8.5, 1H, ArH), 7.38 (br, 2H, NH), 
7.64 (d, J = 10.7, 1H, ArH), 7.67 (d, J = 8.1, 2H, ArH), 8.07 (brS, 2H, ArH), 8.26 (d, J = 
8.5, 1H, ArH), 8.42 (d, J = 7.2, 1H, ArH), 8.60 (d, J = 8.3, 1H, ArH), 9.87 (br, 1H, NH); 
13C NMR at 343K, (DMSO-d6, 125.76 MHz) δ (ppm): 13.6, 18.9, 34.6, 43.1, 44.2, 
56.5, 104.7, 109.1, 118.1, 120.9, 122.6, 124.8, 125.6, 128.7, 129.8, 130.9, 134.2, 
150.8, 163.1, 163.9, 181.3; HRMS (ESI) calcd. for C26H22N5O6 [M + H]
+ 500.1565, 
found 500.1557; difference -1.6 ppm;  νmax (KBr)/cm
-1: 3421 (NH), 3080 (ArH), 1797 
(C=O), 1507 (N-O), 1419 (ArH), 1332 (N-O), 1246 (C-N). 
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6-Amino-2-(2-((2-((3,5-bis(trifluoromethyl)phenyl)amino)-3,4-dioxocyclobut-1-en-
1-yl)amino)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (87) 
 
A solution of 75, (0.14 g, 0.39 mmol, 1 eq) in EtOH (8 mL) was slowly added to a 
mixture of 84, (0.1 g, 0.39 mmol, 1 eq) and Et3N (0.217 mL, 1.56 mmol, 4 eq) in 
EtOH (10 mL). The reaction was stirred at room temperature overnight. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as an olive green amorphous solid. (0.123 g, 56%). 1H NMR at 
343K, (DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 3.90 (m, 2H, CH2), 4.31 (t, J = 6.0, 2H, 
CH2), 6.82 (d, J = 8.4, 1H, ArH), 7.22 (s, 2H, NH2), 7.52 (s, 1H, ArH), 7.58 (t, J = 8.0, 
1H, ArH), 7.89 (s, 2H, ArH), 8.15 (d, J = 8.4, 1H, ArH), 8.37 (d, J = 7.1, 1H, ArH), 8.57 
(d, J = 8.4, 1H, ArH), 9.77 (br, 1H, NH); 13C NMR at 343K, (DMSO-d6, 125.76 MHz) δ 
(ppm): 27.9, 42.9, 108.7, 114.8, 118.4, 119.9, 120.3, 122.2, 122.5, 124.2, 124.7, 
129.0, 130.3, 131.3, 134.3, 141.7, 153.3, 163.3, 164.6, 171.4, 181.3; HRMS (ESI) 
calcd. for C26H17F6N4O4 [M + H]
+ 565.1207, found 565.1231; difference 4.31 ppm; 
νmax (KBr)/cm
-1: 3371 (N-H), 3254 (N-H), 1796 (C=O), 1636 (N-H), 1476 (ArH), 1378 
(C-H), 1276 (C-F), 1250 (C-N). 
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6-Amino-2-(2-((2-((4-nitrophenyl)amino)-3,4-dioxocyclobut-1-en-1-
yl)amino)ethyl)-1H-benzo[de]isoquinoline-1,3(2H)-dione (88) 
 
A solution of 76, (0.1 g, 0.39 mmol, 1 eq) in EtOH (8 mL) was slowly added to a 
mixture of 84, (0.1 g, 0.39 mmol, 1 eq) and Et3N (0.217 mL, 1.56 mmol, 4 eq) in 
EtOH (10 mL).  The reaction was stirred at room temperature overnight. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as an orange amorphous solid. (0.124 g, 67%). 1H NMR at 343K, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 3.95 (t, J = 5.4, 2H, CH2), 4.33 (t, J = 5.5, 2H, 
CH2), 6.84 (d, J = 8.3, 1H, ArH), 7.23 (brS, 2H, ArH), 7.40 (br, 2H, NH2), 7.60 (t, J = 7.8, 
1H, ArH), 8.08 (m, 2H, ArH), 8.17 (d, J = 8.4, 1H, ArH), 8.40 (d, J = 6.8, 1H, ArH), 8.59 
(d, J = 7.8, 1H, ArH), 9.67 (br, 1H, NH) (16 H and not the expected 17 H signals are 
recorded for this compound); 13C NMR at 343K, (DMSO-d6, 125.76 MHz) δ (ppm): 
16.0, 43.0, 108.2, 108.7, 118.1, 120.0, 122.3, 124.3, 125.4, 125.7, 129.0, 130.3, 
131.4, 134.3, 142.0, 145.7, 153.2, 162.6, 163.6, 164.6, 171.5, 181.3 (although not 
symmetrical the squaramide 13C signals appeared as coincident in this spectrum); 
HRMS (ESI) calcd. for C24H18N5O6 [M + H]
+ 472.1252, found 472.1248; difference -
0.79 ppm; νmax (KBr)/cm
-1: 3361 (N-H), 3250 (N-H), 1796 (C=O), 1622 (N-H), 1504 
(N-O), 1432 (ArH), 1368 (C-H), 1328 (N-O), 1247 (C-N).  
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6.6 Synthesis and Characterisation of Compounds Described in Chapter 4 
4,4'-((Methylenebis(4,1-phenylene))bis(azanediyl))bis(3-ethoxycyclobut-3-ene-
1,2-dione) (122) 
 
A solution of 117, (0.037 g, 0.19 mmol, 1 eq) in EtOH (3 mL) was slowly added to a 
mixture of 74, (0.1 g, 0.58 mmol, 3 eq) and zinc triflate (0.014 g, 0.038 mmol, 0.2) in 
EtOH (5 mL). The reaction was stirred at room temperature for 24 hours. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as a tan amorphous solid. (0.079 g, 93%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.40 (t, J = 7.1, 6H, CH3), 3.86 (s, 2H, CH2), 4.74 (q, J = 
7.1, 4H, CH2), 7.27 (d, J = 8.5, 4H, ArH), 7.19 (m, 4H, ArH), 10.69 (s, 2H, NH);
 13C 
NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 10.4, 16.1, 46.2, 69.9, 120.2, 129.6, 136.4, 
137.6, 169.9, 184.0; HRMS (ESI) calcd. for C25H23N2O6 [M + H]
+ 447.1551, found 
447.1540; difference -2.31 ppm. 
4,4'-((Methylenebis(4,1-phenylene))bis(azanediyl))bis(3-(butylamino)cyclobut-3-
ene-1,2-dione) (132) 
 
A mixture of 125, (0.22 mL, 2.24 mmol, 2 eq) and Et3N (0.63 mL, 4.48 mmol, 1 eq) in 
DMF (5 mL) was slowly added to a solution of 122, (0.5 g, 1.12 mmol) in DMF (5 
mL), the reaction mixture was stirred at room temperature for 24 hours. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as an off-white amorphous solid. (0.482 g, 86%). 1H NMR, (DMSO-
d6, 500.13 MHz) δ (ppm), J (Hz): 0.90 (t, J = 7.2, 6H, CH3), 1.34 (q, J = 6.7, 4H, CH2), 
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1.54 (t, J = 7.0, 4H, CH2), 3.59 (s, 4H, CH2), 3.84 (s, 2H, CH2), 7.18 (d, J = 7.8, 4H, ArH), 
7.32 (brS, 4H, ArH), 7.58 (br, 2H, NH), 9.55 (br, 2H, NH); HRMS (ESI) calcd. for 
C29H33N4O4 [M + H]
+ 501.2496, found 501.2515; difference 3.68 ppm; νmax 
(KBr)/cm_1: 3251 (N-H), 3045 (ArH), 1793 (C=O), 1615 (ArH), 1470 (C-H). 
4,4'-((Methylenebis(4,1-phenylene))bis(azanediyl))bis(3-((4-
hydroxybenzyl)amino)cyclobut-3-ene-1,2-dione) (135)  
 
A mixture of 128, (0.276 g, 2.24 mmol, 2 eq) and Et3N (0.63 mL, 4.48 mmol, 4 eq) in 
DMF (5 mL) was slowly added to a solution of 122, (0.5 g, 1.12 mmol, 1 eq) in DMF 
(5 mL), the reaction mixture was stirred at room temperature for 24 hours. The 
precipitate was collected by suction filtration and washed with EtOH and Et2O to 
yield the product as a grey amorphous solid. (0.622 g, 93%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 3.83 (d, J = 8.3, 2H, CH2), 4.66 (s, 4H, CH2), 6.75 (d, J = 
8.3, 4H, ArH), 7.16 (m, 8H, ArH), 7.31 (d, J = 8.0, 4H, ArH), 7.91 (br, 2H, OH), 9.5 (s, 
4H, NH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 16.1, 31.2 47.3, 69.9, 115.8, 
118.6, 129.0, 129.6, 129.9, 136.1, 136.3, 137.4, 137.4, 157.4, 162.8, 164.1, 169.0, 
180.0, 184.3; HRMS (ESI) calcd. for C35H29N4O6 [M + H]
+ 601.2082, found 601.2096; 
difference 2.32 ppm; νmax (KBr)/cm
-1:  3249 (N-H), 3194 (O-H), 3042 (ArH), 1795 
(C=O), 1613 (ArH), 1467 (C-H), 1251 (C-O). 
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4,4'-((Methylenebis(4,1-phenylene))bis(azanediyl))bis(3-((pyridin-4-
ylmethyl)amino)cyclobut-3-ene-1,2-dione) (136) 
 
A mixture of 129, (0.277 mL, 2.24 mmol, 2 eq) and Et3N (0.63 mL, 4.48 mmol, 4 eq) 
in DMF (5 mL) was slowly added to a solution of 122, (0.5 g, 1.12 mmol, 1 eq) in 
DMF (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a beige amorphous solid. (0.587 g, 92%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 3.84 (s, 2H, CH2), 4.83 (d, J = 5.6, 4H, CH2), 7.18 (d, J = 
7.4, 4H, ArH), 7.32 (d, J = 7.7, 4H, ArH), 7.35 (d, J = 4.6, 4H, ArH), 8.02 (s, 2H, NH), 
8.55 (m, 4H, ArH), 9.72 (s, 2H, NH); HRMS (ESI) calcd. for C33H27N6O4 [M + H]
+ 
571.2088, found 571.2095; difference 1.22 ppm; νmax (KBr)/cm
-1: 3245 (N-H), 3038 
(ArH), 1793 (C=O), 1656 (C=N), 1614 (ArH), 1467 (C-H), 1210 (C-N). 
Dimethyl (1,3-phenylenebis(propane-2,2-diyl))dicarbamate (119) 
 
A solution of 118, (10 mL, 43 mmol) in MeOH (30 mL) was stirred for 3 days at 
ambient conditions. The solvent was removed under reduced pressure to yield the 
crude product as a colourless gel-like residue. The residue was left to dry at room 
temperature to yield the product at a white amorphous solid. (12.68 g, 95%). 1H 
NMR, (DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.49 (s, 12H, CH3), 3.44 (s, 6H, CH3), 
7.12 (m, 2H, ArH), 7.18 (m, 1H, ArH), 7.30 (s, 1H, ArH), 7.46 (s, 2H, NH); 13C NMR, 
(DMSO-d6, 125.76 MHz) δ (ppm): 30.1, 33.4, 51.1, 52.5, 54.9, 121.6, 121.7, 122.5, 
122.8, 127.8, 148.0; HRMS (ESI) calcd. for C16H24N2NaO4 [M + Na]
+ 331.1628, found  
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331.1649; difference 6.34 ppm; νmax (KBr)/cm
-1: 3318 (N-H), 3051 (ArH), 1605 
(C=O), 1537 (ArH), 1443 (C-H), 1264 (C-O). 
2,2'-(1,3-Phenylene)bis(propan-2-amine) (120)  
 
A solution of 119, (5.40 g, 17.5 mmol, 1 eq) in n-BuOH (50 mL) containing potassium 
hydroxide (6.00 g, 106.94 mmol, 6.1 eq) was heated under reflux for 24 hours. 
Vacuum evaporation of the solvent left an oily residue which was dissolved in H20 
(25 mL) and extracted in THF (3 x 25 mL), followed by drying over Na2SO4 and 
removal of all volatile material to yield the product as a yellow oil. (3.23 g, 96%). 1H 
NMR, (CDCl3, 500.13 MHz) δ (ppm), J (Hz): 1.50 (s, 12H, CH3), 1.65 (br, 4H, NH2), 
7.29 (m, 1H, ArH), 7.35 (m, 2H, ArH), 7.69 (m, 1H, ArH); 13C NMR, (CDCl3, 125.76 
MHz) δ (ppm): 32.98, 52.57, 120.88, 122.61, 127.96, 150.20; HRMS (ESI) calcd. for 
C24H41N4 [2M + H]
+ 386.3356, found 386.3345; difference -2.85 ppm. 
4,4'-((1,3-Phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-ethoxycyclobut-3-
ene-1,2-dione) (123) 
 
A mixture of 120, (0.113 g, 0.58 mmol, 1 eq) and Et3N (0.32 mL, 2.32 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 74, (0.26 mL, 1.76 mmol, 3 eq) in 
EtOH (5 mL), the reaction mixture was stirred at room temperature for 24 hours. 
The reaction was monitored by TLC and was concentrated on a rotary evaporator to 
yield a yellow residue. The crude product was purified by column chromatography 
(silica gel, 3% MeOH in DCM). The solvent was removed under reduced pressure to 
yield a sticky yellow residue. (0.189 g, 74%). 1H NMR, (CDCl3, 500.13  MHz) δ (ppm), 
J (Hz): 1.13 (m, 6H, CH3), 1.68 (s, 12H, CH3), 4.44 (m, 4H, CH2), 7.19 (brS, 2H, ArH), 
7.43 (brS, 1H, ArH), 7.93 (brS, 1H, ArH); 13C NMR, (CDCl3, 125.76 MHz) δ (ppm): 
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15.3, 30.8, 53.5, 58.4, 68.6, 121.8, 123.3, 128.5, 146.8, 172.0, 176.3, 184.1, 190.1; 
HRMS (ESI) calcd. for C24H29N2O6 [M + H]
+ 441.2020, found 441.2011; difference -
2.05 ppm. 
4,4'-((1,3-phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-
(butylamino)cyclobut-3-ene-1,2-dione) (137) 
 
A mixture of 125, (0.27 mL, 2.72 mmol, 4 eq) and Et3N (0.38 mL, 2.72 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 123, (0.30 g, 0.68 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as an off-white amorphous solid. (0.315 g, 93%). 1H NMR, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 0.88 (t, J = 7.4, 6H, CH3), 1.31 (m, 4H, CH2), 
1.48 (m, 4H, CH2), 1.73 (s, 12H, CH3), 3.53 (q, J = 6.5, 4H, CH2), 7.32 (m, 4H, ArH), 
7.44 (s, 2H, NH), 7.81 (s, 2H, NH); 13C NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 13.9, 
19.4, 30.9, 33.1, 43.5, 57.8, 79.6, 122.3, 124.1, 128.8, 147.5, 168.3, 169.1, 180.9, 
183.3; HRMS (ESI) calcd. for C28H39N4O4 [M + H]
+ 495.2966, found 495.2985; 
difference 3.92 ppm; νmax (KBr)/cm
-1: 3233 (N-H), 2959 (ArH), 1792 (C=O), 1578 
(ArH), 1457 (C-H). 
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4,4'-((1,3-Phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-
(decylamino)cyclobut-3-ene-1,2-dione) (138) 
 
A mixture of 126, (0.55 mL, 2.72 mmol, 4 eq) and Et3N (0.38 mL, 2.72 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 123, (0.30 g, 0.68 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as an off-white amorphous solid. (0.358 g, 79%). 1H NMR, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 0.85 (t, J = 6.8, 6H, CH3), 1.25 (m, 28H, CH2), 
1.49 (t, J = 6.7, 4H, CH2), 1.72 (s, 12H, CH3), 7.32 (m, 3H, ArH), 7.44 (s, 1H, ArH), 7.80 
(br, 2H, NH); 13C NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 14.4, 22.5, 26.3, 29.0, 29.1, 
29.4, 29.5, 30.9, 31.1, 31.7, 43.8, 57.8, 122.3 124.1, 128.7, 147.5, 168.3, 169.1, 
183.2; HRMS (ESI) calcd. for C80H125N8O8 [2M + H]
+ 1325.9615, found 1325.9669; 
difference 4.08 ppm; νmax (KBr)/cm
-1: 3224 (N-H), 2923 (ArH), 1792 (C=O), 1571 
(ArH), 1458 (C-H). 
4,4'-((1,3-Phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-
(benzylamino)cyclobut-3-ene-1,2-dione) (139) 
 
A mixture of 127, (0.297 mL, 2.72 mmol, 4 eq) and Et3N (0.38 mL, 2.72 mmol, 4 eq) 
in EtOH (5 mL) was slowly added to a solution of 123, (0.30 g, 0.68 mmol, 1 eq) in 
EtOH (5 mL).  The reaction mixture was stirred at room temperature for 24 hours. 
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The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a white amorphous solid. (0.29 g, 76%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.71 (s, 12H, CH3), 4.73 (d, J = 6.1, 4H, CH2), 7.34 (m, 
14H, ArH), 7.85 (br, 4H, NH); 13C NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 30.8, 47.4, 
56.5, 57.9, 122.3, 124.1, 128.0, 128.1, 128.8, 129.1, 139.1, 147.4, 168.5, 168.7, 
183.3; HRMS (ESI) calcd. for C34H35N4O4 [M + H]
+ 563.2653, found 563.2673; 
difference 3.55 ppm; νmax (KBr)/cm
-1: 3229 (N-H), 2966 (ArH), 1793 (C=O), 1442 (C-
H). 
4,4'-((1,3-Phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-((4-
hydroxybenzyl)amino)cyclobut-3-ene-1,2-dione) (140) 
 
A mixture of 128, (0.34 g, 2.72 mmol, 4 eq) and Et3N (0.38 mL, 2.72 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 123, (0.30 g, 0.68 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a beige amorphous solid. (0.339 g, 84%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.71 (s, 12H, CH3), 4.60 (s, 4H, CH2), 6.75 (d, J = 7.9, 4H, 
ArH), 7.14 (d, J = 7.6, 4H, ArH), 7.29 (brS, 3H, ArH), 7.42 (s, 1H, ArH), 7.71 (s, 2H, 
NH), 7.80 (s, 2H, NH), 9.41 (br, 2H, OH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 
12.2, 19.0, 30.8, 46.1, 47.1, 56.5, 57.8, 115.8, 122.3, 124.1, 147.4, 157.3, 168.4, 
168.5, 181.0, 183.3; HRMS (ESI) calcd. for C34H35N4O6 [M + H]
+ 595.2551, found 
595.2568; difference 2.85 ppm; νmax (KBr)/cm
-1: 3223 (N-H), 2972 (ArH), 1792 (C=O) 
1570 (ArH), 1367 (C-H), 1230 (C-O). 
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4,4'-((1,3-Phenylenebis(propane-2,2-diyl))bis(azanediyl))bis(3-((pyridin-4-
ylmethyl)amino)cyclobut-3-ene-1,2-dione) (141) 
 
A mixture of 129, (0.276 mL, 2.72 mmol, 4 eq) and Et3N (0.38 mL, 2.72 mmol, 4 eq) 
in EtOH (5 mL) was slowly added to a solution of 123, (0.30 g, 0.68 mmol, 1 eq) in 
EtOH (5 mL). The precipitate was collected by suction filtration and washed with 
EtOH and Et2O to yield the product as a light yellow amorphous solid. (0.372 g, 
96%). 1H NMR, (DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.73 (s, 12H, CH3), 4.77 (d, J 
= 6.4, 4H, CH2), 7.35 (m, 8H, ArH), 7.97 (br, 4H, NH), 8.54 (m, 4H, ArH); 
13C NMR 
(DMSO-d6, 125.76 MHz): δ (ppm): 30.9, 44.1, 46.2, 58.0, 121.8, 122.3, 122.6, 122.9, 
123.5, 124.2, 128.8, 147.5, 148.1, 149.8, 150.3, 168.8, 168.8, 181.5, 183.2; HRMS 
(ESI) calcd. for C32H33N6O4 [M + H]
+ 565.2558, found 565.2572; difference 2.47 ppm; 
νmax (KBr)/cm
-1: 3236 (N-H), 2967 (ArH), 1794 (C=O) 1667 (C=N), 1535 (ArH), 1413 
(C-H), 1209 (C-N). 
4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-
ethoxycyclobut-3-ene-1,2-dione) (124)  
 
A mixture of 121, (0.2 g, 0.644 mmol, 1 eq) and Et3N (0.55 mL, 3.86 mmol, 6.0 eq) in 
EtOH (5 mL) was slowly added to a mixture of 74, (0.286 mL, 1.932 mmol, 3 eq) and 
zinc triflate (0.047 g, 0.13 mmol, 0.2 eq) in EtOH (5 mL), the reaction mixture was 
heated under reflux for 7 days. The reaction was monitored by TLC and was 
concentrated on a rotary evaporator to yield a dark yellow residue. The crude 
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product was purified by column chromatography (silica gel, 3% MeOH in DCM). The 
solvent was removed under reduced pressure to yield the product as a yellow 
liquid. (0.23 g, 59%). 1H NMR, (CDCl3, 500.13 MHz) δ (ppm), J (Hz): 1.16 (m, 18H, 
CH3), 2.57 (m, 8H, CH2), 3.95 (s, 2H, CH2), 4.57 (brS, 4H, CH2), 6.92 (s, 4H, ArH), 8.11 
(br, 2H, NH); 13C NMR, (CDCl3, 125.76 MHz) δ (ppm): 13.57, 14.60, 23.68, 40.32, 
68.55, 126.07, 129.84, 140.08, 140.37, 171.14, 177.99, 182.74, 188.66; HRMS (ESI) 
calcd. for C33H39N2O6 [M + H]
+ 559.2803, found 559.2789; difference -2.39 ppm. 
4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-
(butylamino)cyclobut-3-ene-1,2-dione)  (142) 
 
A mixture of 125, (0.21 mL, 2.15 mmol, 4 eq) and Et3N (0.30 mL, 2.15 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 124, (0.30 g, 0.54 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as an off-white amorphous solid (0.182 g, 55%). 1H NMR, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.16 (m, 30H, CH2 and CH3), 3.30 (m, 8H, 
CH2), 3.90 (s, 2H, CH2), 7.02 (s, 4H, ArH), 7.49 (br, 2H, NH), 8.68 (br, 2H, NH); 
13C 
NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 14.0, 14.8, 19.4, 24.7, 33.2, 43.7, 79.6, 
127.0, 132.5, 140.6, 141.2, 167.6, 168.7, 181.7, 184.3; HRMS (ESI) calcd. for 
C37H49N4O4 [M + H]
+ 613.3748, found 613.3767; difference 3.07 ppm; νmax (KBr)/cm
-
1: 3238 (N-H), 2963 (ArH), 1796 (C=O), 1527 (ArH), 1445 (C-H). 
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4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-
(decylamino)cyclobut-3-ene-1,2-dione) (143) 
 
A mixture of 126, (0.43 mL, 2.15 mmol, 4 eq) and Et3N (0.30 mL, 2.15 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 124, (0.30 g, 0.54 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a white amorphous solid. (0.139 g, 33%). 1H NMR, (DMSO-
d6, 500.13 MHz) δ (ppm), J (Hz): 0.85 (t, J = 6.8, 6H, CH3), 1.08 (t, J = 7.5, 12H, CH3), 
1.51 (m, 32H, CH2), 2.52 (m, 8H, CH2), 3.54 (brS, 4H, CH2), 3.90 (s, 2H, CH2), 7.02 (s, 
4H, ArH), 7.48 (br, 2H, NH), 8.66 (br, 2H, NH); 13C NMR, (DMSO-d6, 125.76 MHz) δ 
(ppm): 184.3, 168.7, 168.6, 167.5, 141.5, 141.1, 140.6, 127.0, 79.6, 79.4, 79.1, 31.7, 
31.1, 29.4, 29.3, 29.1, 29.0, 26.2, 24.7, 22.5, 14.8, 14.4; HRMS (ESI) calcd. for 
C49H73N4O4 [M + H]
+ 781.5626, found 781.5672; difference 5.82 ppm; νmax (KBr)/cm
-
1: 3245 (N-H), 2925 (ArH), 1797 (C=O), 1528 (ArH), 1441 (C-H). 
4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-
(benzylamino)cyclobut-3-ene-1,2-dione) (144) 
 
A mixture of 127, (0.24 mL, 2.15 mmol, 4 eq) and Et3N (0.30 mL, 2.15 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 124, (0.30 g, 0.54 mmol, 1 eq) in 
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EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as an off-white amorphous solid. (0.219 g, 59%). 1H NMR, 
(DMSO-d6, 500.13 MHz) δ (ppm), J (Hz): 1.04 (t, J = 7.1, 12H, CH3), 3.30 (m, 8H, CH2), 
3.88 (s, 2H, CH2), 4.77 (s, 4H, CH2), 7.00 (s, 4H, ArH), 7.32 (m, 10H, ArH), 7.92 (br, 
2H, NH), 8.69 (br, 2H, NH); 13C NMR, (DMSO-d6, 125.76 MHz) δ (ppm): 184.4, 168.3, 
167.8, 141.2, 140.6, 139.3, 132.4 129.0, 128.8, 128.6, 128.4, 127.8, 127.3, 127.2, 
127.0, 126.6, 79.6, 47.3, 24.6, 14.8; HRMS (ESI) calcd. for C43H45N4O4 [M + H]
+ 
681.3435, found 681.3447; difference 1.7 ppm;  νmax (KBr)/cm
-1: 3225 (N-H), 2964 
(ArH), 1797 (C=O), 1527 (ArH), 1451 (C-H). 
4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-((4-
hydroxybenzyl)amino)cyclobut-3-ene-1,2-dione) (145) 
 
A mixture of 128, (0.31 g, 2.52 mmol, 4 eq) and Et3N (0.35 mL, 2.52 mmol, 4 eq) in 
EtOH (5 mL) was slowly added to a solution of 124, (0.35 g, 0.63 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a brown amorphous solid. (0.122 g, 27%). 1H NMR, (DMSO-
d6, 500.13 MHz) δ (ppm), J (Hz): 1.04 (s, 12H, CH3), 3.87 (s, 2H, CH2), 4.64 (s, 4H, 
CH2), 6.74 (s, 4H, ArH), 7.08 (m, 8H, ArH), 7.85 (br, 2H, NH), 8.64 (br, 2H, NH), 9.39 
(br, 2H, OH), 2.42 (8H, CH2 under solvent peak according to COSY);
 13C NMR, 
(DMSO-d6, 125.76 MHz) δ (ppm): 12.2, 14.2, 24.6, 46.2, 47.0, 115.3, 115.8, 127.0, 
129.5, 132.5, 141.1, 157.2, 167.7, 168.2, 184.4; HRMS (ESI) calcd. for C43H45N4O6 [M 
+ H]+ 713.3334, found 713.3356; difference 3.08 ppm; νmax (KBr)/cm
-1: 3236 (N-H), 
2966 (ArH), 1798 (C=O), 1578 (ArH), 1444 (C-H), 1257 (C-O). 
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4,4'-((methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-((pyridin-4-
ylmethyl)amino)cyclobut-3-ene-1,2-dione) (146) 
 
A mixture of 129, (0.256 mL, 2.52 mmol, 4 eq) and Et3N (0.35 mL, 2.52 mmol, 4 eq) 
in EtOH (5 mL) was slowly added to a solution of 124, (0.35 g, 0.63 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a beige amorphous solid. (0.292 g, 68%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.05 (t, J = 7.0, 12H, CH3), 2.44 (q, J = 7.4, 8H, CH2), 
3.89 (s, 2H, CH2), 4.82 (s, 4H, CH2), 7.01 (brS, 4H, ArH), 7.35 (brS, 4H, ArH),  7.96 (br, 
2H, NH), 8.56 (brS, 4H, ArH), 8.80 (s, 2H, NH); 13C NMR (DMSO-d6, 125.76 MHz): δ 
(ppm): 13.8, 14.8, 19.0, 24.6, 41.1, 46.2, 56.5, 122.4, 127.0, 127.2, 141.3, 148.4, 
150.2, 168.0, 168.5, 182.2; HRMS (ESI) calcd. for C41H43N6O4 [M + H]
+ 683.3340, 
found 683.3326; difference -2.04 ppm νmax (KBr)/cm
-1: 3240 (N-H), 2967 (ArH), 1797 
(C=O), 1674 (C=N), 1581 (ArH), 1464 (C-H), 1211 (C-N). 
4,4'-((Methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-((pyridin-3-
ylmethyl)amino)cyclobut-3-ene-1,2-dione) (147) 
 
A mixture of 130, (0.256 mL, 2.52 mmol, 4 eq) and Et3N (0.35 mL, 2.52 mmol, 4 eq) 
in EtOH (5 mL) was slowly added to a solution of 124, (0.35 g, 0.63 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
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The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a beige amorphous solid. (0.284 g, 66%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.03 (t, J = 7.3, 12H, CH3), 2.45 (m, 8H, CH2), 3.88 (s, 
2H, CH2), 4.80 (m, 4H, CH2), 7.00 (s, 4H, ArH), 7.49 (d, J = 5.1, 2H, ArH), 7.76 (m, 2H, 
ArH), 8.60 (m, 4H, ArH), 8.75 (s, 2H, NH); 13C NMR (DMSO-d6, 125.76 MHz): δ (ppm): 
13.8, 14.8, 24.6, 41.1, 45.0, 123.9, 124.1, 126.6, 127.1, 132.4, 134.9, 135.6, 140.6, 
141.3, 149.1, 168.0, 168.3, 184.3; HRMS (ESI) calcd. for C41H43N6O4 [M + H]
+ 
683.3340, found 683.3333; difference -1.1 ppm;  νmax (KBr)/cm
-1: 3225 (N-H), 2964 
(ArH), 1798 (C=O), 1664 (C=N), 1425 (C-H), 1210 (C-N). 
4,4'-((methylenebis(2,6-diethyl-4,1-phenylene))bis(azanediyl))bis(3-((pyridin-2-
ylmethyl)amino)cyclobut-3-ene-1,2-dione) (148) 
 
A mixture of 131, (0.256 mL, 2.52 mmol, 4 eq) and Et3N (0.35 mL, 2.52 mmol, 4 eq) 
in EtOH (5 mL) was slowly added to a solution of 124, (0.35 g, 0.63 mmol, 1 eq) in 
EtOH (5 mL). The reaction mixture was stirred at room temperature for 24 hours. 
The precipitate was collected by suction filtration and washed with EtOH and Et2O 
to yield the product as a beige amorphous solid. (0.264 g, 61%). 1H NMR, (DMSO-d6, 
500.13 MHz) δ (ppm), J (Hz): 1.06 (m, 12H, CH3), 3.90 (s, 2H, CH2), 4.90 (s, 4H, CH2), 
7.02 (s, 4H, ArH), 7.37 (brS, 4H, ArH), 7.82 (s, 2H, ArH), 8.11 (br, 2H, NH), 8.59 (s, 2H, 
ArH), 8.88 (br, 2H, NH), 2.48 (8H, CH2 under solvent peak according to COSY); 
13C 
NMR (DMSO-d6, 125.76 MHz): δ (ppm): 14.9, 19.0, 24.6, 41.0, 48.7, 56.5, 122.0, 
123.1, 127.0, 132.5, 137.6, 140.6, 141.2, 149.5, 157.7, 167.9, 168.6, 184.4; HRMS 
(ESI) calcd. for C41H43N6O4 [M + H]
+ 683.3340, found 683.3342; difference 0.24 ppm;  
νmax (KBr)/cm
-1: 3245 (N-H), 2966 (ArH), 1797 (C=O), 1674 (C=N), 1583 (ArH), 1437 
(C-H), 1212 (C-N). 
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Appendix 2: 
 
2A 1: The 1H NMR spectrum of 74 (500.13 MHz, CDCl3) 
 
 
2A 2: The 13C NMR spectrum of 74 (125.76 MHz, CDCl3) 
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2A 3: The 1H NMR spectrum of 75 (500.13 MHz, DMSO-d6). 
 
 
2A 4: The 13C NMR spectrum of 75 (125.76 MHz, DMSO-d6) 
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2A 5: The 1H NMR spectrum of 76 (500.13 MHz, DMSO-d6). 
 
 
2A 6: The 13C NMR spectrum of 76 (125.76 MHz, DMSO-d6) 
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2A 7: The 1H NMR spectrum of 78 (500.13 MHz, DMSO-d6). 
 
 
2A 8: The 13C NMR spectrum of 78 (125.76 MHz, DMSO-d6) 
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2A 9: The 1H NMR spectrum of 79 (500.13 MHz, DMSO-d6). 
 
 
2A 10: The 13C NMR spectrum of 79 (125.76 MHz, DMSO-d6) 
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2A 11: The 1H NMR spectrum of 81 (500.13 MHz, DMSO-d6). 
 
2A 12: The 13C NMR spectrum of 81 (125.76 MHz, DMSO-d6) 
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2A 13: The 1H NMR spectrum of 82 (500.13 MHz, DMSO-d6). 
 
 
2A 14: The 13C NMR spectrum of 82 (125.76 MHz, DMSO-d6) 
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2A 15: The 1H NMR spectrum of 83 (500.13 MHz, DMSO-d6). 
 
 
2A 16: The 13C NMR spectrum of 83 (125.76 MHz, DMSO-d6) 
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2A 17: The 1H NMR spectrum of 84 (500.13 MHz, DMSO-d6). 
 
 
2A 18: The 13C NMR spectrum of 84 (125.76 MHz, DMSO-d6) 
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2A 19: The 1H NMR spectrum of 85 at 298 K (500.13 MHz, DMSO-d6). 
 
 
2A 20: The 1H NMR spectrum of 85 at 343 K (500.13 MHz, DMSO-d6). 
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2A 21: The 13C NMR spectrum of 85 at 298 K (125.76 MHz, DMSO-d6) 
 
 
2A 22: The 13C NMR spectrum of 85 at 343 K (125.76 MHz, DMSO-d6) 
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2A 23: The 1H NMR spectrum of 86 at 298 K (500.13 MHz, DMSO-d6). 
 
 
2A 24: The 1H NMR spectrum of 86 at 343 K (500.13 MHz, DMSO-d6) 
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2A 25: The 13C NMR spectrum of 86 at 298 K (125.76 MHz, DMSO-d6) 
 
 
2A 26: The 13C NMR spectrum 86 at 343 K (125.76 MHz, DMSO-d6) 
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2A 27: The 1H NMR spectrum of 87 at 298 K (500.13 MHz, DMSO-d6). 
  
 
2A 28: The 1H NMR spectrum of 87 at 343 K (500.13 MHz, DMSO-d6) 
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2A 29: The 13C NMR spectrum of 87 at 298 K (125.76 MHz, DMSO-d6) 
 
 
2A 30: The 13C NMR spectrum of 87 at 343 K (125.76 MHz, DMSO-d6) 
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2A 31: The 1H NMR spectrum of 88 at 298 K (500.13 MHz, DMSO-d6). 
 
 
2A 32: The 1H NMR spectrum of 88 at 343 K (500.13 MHz, DMSO-d6). 
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2A 33: The 13C NMR spectrum of 88 at 298 K (125.76 MHz, DMSO-d6) 
 
 
2A 34: The 13C NMR spectrum of 88 at 343 K (125.76 MHz, DMSO-d6) 
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2A 35: Changes in UV/Visible spectra upon increasing concentration of 85 in DMSO 
(0 – 57 µM). Inset: Plot of absorbance at 445 nm as a function of  increasing 
concentration of 85. 
2A 36: Changes in UV/Visible spectra upon increasing concentration of 86 in DMSO 
(0 – 67 µM). Inset: Plot of absorbance at 420 nm as a function of  increasing 
concentration of 86. 
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2A 37:  Changes in UV/Visible spectra upon increasing concentration of 87 in DMSO 
(0 – 60 µM). Inset: Plot of absorbance at 445 nm as a function of  increasing 
concentration of 87. 
2A 38: Changes in UV/Visible spectra upon increasing concentration of 88 in DMSO 
(0 – 70 µM). Inset: Plot of absorbance at (a) 545 nm and (b) 420 nm as a function of  
increasing concentration of 88. 
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2A 39: Changes in the UV/Visible spectrum of 85 (11.9 µM) with increasing TBA 
acetate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
325 nm (orange), 445 nm (blue) and 390 nm (grey) as a function of TBA acetate 
equivalents. 
 
2A 40: Changes in the UV/Visible spectrum of 85 (11.9 µM) with increasing TBA 
chloride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
390 nm (grey), 445 nm (blue) and 325 nm (orange) as a function of TBA chloride 
acetate equivalents. 
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2A 41: Changes in the UV/Visible spectrum of 85 (11.9 µM) with increasing TBA 
fluoride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
390 nm (orange), 445 nm (blue) and 325 nm (grey) as a function of TBA fluoride 
equivalents. 
2A 42: Changes in the UV/Visible spectrum of 85 (11.9 µM) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 325 nm (grey), 445 nm (blue) and 390 nm (orange) as a function of TBA 
phosphate equivalents. 
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2A 43: Bind fit graph of UV titration of 85 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs).  
 
2A 44: Speciation graph of UV titration of 85 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). 
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2A 45: Changes in the UV/Visible spectrum of 85 (11.9 µM) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 325 nm (grey), 445 nm (blue) and 390 nm (orange) as a function of TBA sulphate 
equivalents. 
 
2A 46: Bind fit graph of UV titration of 85 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs).  
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2A 47: Speciation graph of UV titration of 85 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). 
 
2A 48: Changes in the UV/Visible spectrum of 85 (11.9 µM, DMSO) with 70 
equivalents (700 µM) of different solution of anions as TBA salts in DMSO ( AcO-, Cl-, 
F-, PO4
3- and SO4
2-). 
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2A 49: Changes in the UV/Visible spectrum of 86 (11.9 µM) with increasing TBA 
acetate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
285 nm (yellow), 460 nm (orange), 375 nm (grey) and 525 nm (blue) as a function of 
TBA acetate equivalents. 
2A 50: Changes in the UV/Visible spectrum of 86 (11.9 µM) with increasing TBA 
chloride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
285 nm (yellow), 420 nm (orange), 375 nm (grey) and 525 nm (blue) as a function of 
TBA chloride equivalents. 
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2A 51: Changes in the UV/Visible spectrum of 86 (11.9 µM) with increasing TBA 
fluoride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
285 nm (yellow), 460 nm (orange), 375 nm (grey) and 525 nm (blue) as a function of 
TBA fluoride equivalents.  
2A 52: Changes in the UV/Visible spectrum of 86 (11.9 µM) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 285 nm (yellow), 450 nm (orange), 345 nm (grey) and 525 nm (blue) as a function 
of TBA phosphate equivalents. 
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2A 53: Bind fit graph of UV titration of 86 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs).  
 
2A 54: Speciation graph of UV titration of 86 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). 
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2A 55: Changes in the UV/Visible spectrum of 86 (11.9 µM) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 285 nm (dark blue), 420 nm (grey), 450 nm (orange), 345 nm (yellow) and 525 nm 
(light blue) as a function of TBA sulphate equivalents. 
 
2A 56: Bind fit graph of UV titration of 86 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs).  
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2A 57: Speciation graph of UV titration of 86 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). 
 
2A 58: Changes in the UV/Visible spectrum of 86 (11.9 µM, DMSO) with 70 
equivalents (700 µM) of different solution of anions as TBA salts in DMSO ( AcO-, Cl-, 
F-, PO4
3- and SO4
2-). 
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2A 59: Changes in the UV/Visible spectrum of 87 (11.9 µM) with increasing TBA 
acetate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
325 nm (orange) and 390 nm (blue) as a function of TBA acetate equivalents. 
2A 60: Changes in the UV/Visible spectrum of 87 (11.9 µM) with increasing TBA 
chloride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
325 nm (orange) and 380 nm (blue) as a function of TBA chloride equivalents. 
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2A 61: Changes in the UV/Visible spectrum of 87 (11.9 µM) with increasing TBA 
fluoride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
325 nm (orange) and 380 nm (blue) as a function of TBA fluoride equivalents. 
2A 62: Changes in the UV/Visible spectrum of 87 (11.9 µM) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 325 nm (orange) and 390 nm (blue) as a function of TBA phosphate equivalents. 
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2A 63: Bind fit graph of UV titration of 87 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs).  
 
2A 64: Speciation graph of UV titration of 87 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). 
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2A 65: Changes in the UV/Visible spectrum of 87 (11.9 µM) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 325 nm (orange)  and 390 nm (blue) as a function of TBA sulphate equivalents. 
 
2A 66: Bind fit graph of UV titration of 87 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs).  
179 
 
 
2A 67: Speciation graph of UV titration of 87 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). 
 
2A 68: Changes in the UV/Visible spectrum of 87 (11.9 µM, DMSO) with 70 
equivalents (700 µM) of different solution of anions as TBA salts in DMSO ( AcO-, Cl-, 
F-, PO4
3- and SO4
2-). 
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2A 69: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing TBA 
acetate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of TBA acetate 
equivalents. 
2A 70: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing TBA 
chloride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of TBA chloride 
equivalents. 
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2A 71: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing TBA 
fluoride equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance at 
420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of TBA fluoride 
equivalents. 
2A 72: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of TBA 
phosphate equivalents. 
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2A 73: Bind fit graph of UV titration of 88 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs).  
 
2A 74: Speciation graph of UV titration of 88 (11.9 µM, DMSO) with increasing TBA 
phosphate equivalents in DMSO (0 - 70 eqs). 
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2A 75: Changes in the UV/Visible spectrum of 88 (11.9 µM) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). Inset: Plot of the change in absorbance 
at 420 nm (orange), 325 nm (grey) and 545 nm (blue) as a function of TBA sulphate 
equivalents (0 - 70 eqs). 
 
2A 76: Bind fit graph of UV titration of 88 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs).  
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2A 77: Speciation graph of UV titration of 88 (11.9 µM, DMSO) with increasing TBA 
sulphate equivalents in DMSO (0 - 70 eqs). 
2A 78: Changes in the UV/Visible spectrum of 88 (11.9 µM, DMSO) with 70 
equivalents (700 µM) of different solution of anions as TBA salts in DMSO ( AcO-, Cl-, 
F-, PO4
3- and SO4
2-). 
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2A 79: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 360 
nm with increasing TBA acetate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
emission intensity at 522 nm as a function of 0 – 70 equivalents of TBA acetate. 
2A 80: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 360 
nm with increasing TBA chloride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA chloride equivalents. 
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2A 81: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 360 
nm with increasing TBA fluoride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA fluoride equivalents. 
2A 82: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 360 
nm with increasing TBA phosphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
the change in emmission intensity at 522 nm as a function of TBA phosphate 
equivalents. 
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2A 83: Changes in the fluoresence emmission spectrum of 85 (11.9 µM) at λex 360 
nm with increasing TBA sulphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA sulphate equivalents. 
 
2A 84: Changes in the fluoresence emmission spectrum of 85 (11.9 µM, DMSO) at  
λex 360 nm with 70 equivalents (700 µM) of different solution of anions as TBA salts 
in DMSO ( AcO-, Cl-, F-, PO4
3- and SO4
2-) 
188 
 
2A 85: Changes in the fluoresence emmission spectrum of 86 (11.9 µM) at λex 430 
nm with increasing TBA acetate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA acetate equivalents. 
2A 86: Changes in the fluoresence emmission spectrum of 86 (11.9 µM) at λex 430 
nm with increasing TBA chloride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA chloride equivalents. 
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2A 87: Changes in the fluoresence emmission spectrum of 86 (11.9 µM) at λex 430 
nm with increasing TBA fluoride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA fluoride equivalents. 
2A 88: Changes in the fluoresence emmission spectrum of 86 (11.9 µM) at λex 430 
nm with increasing TBA phosphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
the change in emmission intensity at 522 nm as a function of TBA phosphate 
equivalents. 
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2A 89: Changes in the fluoresence emmission spectrum of 86 (11.9 µM) at λex 430 
nm with increasing TBA sulphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA sulphate equivalents. 
 
2A 90: Changes in the fluoresence emmission spectrum of 86 (11.9 µM, DMSO) at  
λex 430 nm with 70 equivalents (700 µM) of different solution of anions as TBA salts 
in DMSO ( AcO-, Cl-, F-, PO4
3- and SO4
2-). 
191 
 
2A 91: Changes in the fluoresence emmission spectrum of 87 (11.9 µM) at λex 355 
nm with increasing TBA acetate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA acetate equivalents. 
2A 92: Changes in the fluoresence emmission spectrum of 87 (11.9 µM) at λex 355 
nm with increasing TBA chloride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA chloride equivalents. 
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2A 93: Changes in the fluoresence emmission spectrum of 87 (11.9 µM) at λex 355 
nm with increasing TBA fluoride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA fluoride equivalents. 
2A 94: Changes in the fluoresence emmission spectrum of 87 (11.9 µM) at λex 355 
nm with increasing TBA phosphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
the change in emmission intensity at 522 nm as a function of TBA phosphate 
equivalents. 
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2A 95: Changes in the fluoresence emmission spectrum of 87 (11.9 µM) at λex 355 
nm with increasing TBA sulphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA sulphate equivalents. 
 
2A 96: Changes in the fluoresence emmission spectrum of 87 (11.9 µM, DMSO) at  
λex 355 nm with 70 equivalents (700 µM) of different solution of anions as TBA salts 
in DMSO ( AcO-, Cl-, F-, PO4
3- and SO4
2-) 
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2A 97: Changes in the fluoresence emmission spectrum of 88 (11.9 µM) at λex 460 
nm with increasing TBA acetate equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA acetate equivalents. 
2A 98: Changes in the fluoresence emmission spectrum of 88 (11.9 µM) at λex 460 
nm with increasing TBA acetate eqivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA acetate eqivalents. 
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2A 99: Changes in the fluoresence emmission spectrum of 88 (11.9 µM) at λex 460 
nm with increasing TBA fluoride equivalents in DMSO (0 – 70 eqs). Inset: Plot of the 
change in emmission intensity at 522 nm as a function of TBA fluoride equivalents. 
2A 100: Changes in the fluoresence emmission spectrum of 88 (11.9 µM) at λex 460 
nm with increasing TBA phosphate equivalents in DMSO (0 – 70 eqs). Inset: Plot of 
the change in emmission intensity at 522 nm as a function of TBA phosphate 
equivalents. 
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2A 101: Changes in the fluoresence emmission spectrum of 88 (11.9 µM) at λex 460 
nm with increasing TBA sulphate phosphate equivalents in DMSO (0 – 70 eqs). Inset: 
Plot of the change in emmission intensity at 522 nm as a function of TBA sulphate 
equivalents. 
 
2A 102: Changes in the fluoresence emmission spectrum of 88 (11.9 µM, DMSO) at  
λex 460 nm with 70 equivalents (700 µM) of different solution of anions as TBA salts 
in DMSO ( AcO-, Cl-, F-, PO4
3- and SO4
2-) 
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(a) 
(b) 
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2A 103: Changes in the 1H NMR spectrum of 85 (2.5 × 10-3 M) upon the addition of 
20 eqvivalents of anions as TBA salts in DMSO-d6 (AcO
-, Cl-, F-, PO4
3- and SO4
2-). (a): 
Aromatic region of 85. (b): Formation of HF2 upon the addition of 20 equivalents 
TBA fluoride to 85 in DMSO-d6.
121, 122 The differing spectroscopic response of 
compound 85 upon the addition of 20 eqvivalents of anions as TBA salts in DMSO-d6 
(AcO-, Cl-, F-, PO4
3- and SO4
2-). Changes in the appearance of a sample of 85 (2.5 × 
10-3 M)  upon the addition 20 equivalents of anions as TBA salts in DMSO-d6 ( AcO
-, 
Cl-, F-, PO4
3- and SO4
2-). (c) With the naked eye and (d) Under UV illumination. 
 
(a) 
(c) 
(d) 
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2A 104: Changes in the 1H NMR spectrum of 86 (2.5 × 10-3 M) upon the addition of 
20 eqvivalents of anions as TBA salts in DMSO-d6 (AcO
-, Cl-, F-, PO4
3- and SO4
2-). (a): 
Aromatic region of 86. (b): Formation of HF2 upon the addition of 20 equivalents 
TBA fluoride to 86 in DMSO-d6.
121, 122 The differing spectroscopic response of 
compound 86 upon the addition of 20 eqvivalents of anions as TBA salts in DMSO-d6 
(AcO-, Cl-, F-, PO4
3- and SO4
2-). Changes in the appearance of a sample of 86 (2.5 × 
10-3 M) upon the addition 20 equivalents of anions as TBA salts in DMSO-d6 ( AcO
-, 
Cl-, F-, PO4
3- and SO4
2-). (c) With the naked eye and (d) Under UV illumination. 
(b) 
(c) 
(d) 
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(b) 
(a) 
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2A 105: Changes in the 1H NMR spectrum of 87 (2.5 × 10-3 M) upon the addition of 
20 eqvivalents of anions as TBA salts in DMSO-d6 (AcO
-, Cl-, F-, PO4
3- and SO4
2-). (a): 
Aromatic region of 87. (b): Formation of HF2 upon the addition of 20 equivalents 
TBA fluoride to 87 in DMSO-d6.
121, 122 The differing spectroscopic response of 
compound 87 upon the addition of 20 eqvivalents of anions as TBA salts in DMSO-d6 
(AcO-, Cl-, F-, PO4
3- and SO4
2-). Changes in the appearance of a sample of 87 (2.5 × 
10-3 M) upon the addition 20 equivalents of anions as TBA salts in DMSO-d6 ( AcO
-, 
Cl-, F-, PO4
3- and SO4
2-). (c) With the naked eye and (d) Under UV illumination. 
 
 
(a) 
(d) 
(c) 
202 
 
 
 
2A 106: Changes in the 1H NMR spectrum of 88 (2.5 × 10-3 M) upon the addition of 
20 eqvivalents of anions as TBA salts in DMSO-d6 (AcO
-, Cl-, F-, PO4
3- and SO4
2-). (a): 
Aromatic region of 88. (b): Formation of HF2 upon the addition of 20 equivalents 
TBA fluoride to 88 in DMSO-d6.
121, 122 The differing spectroscopic response of 
compound 88 upon the addition of 20 eqvivalents of anions as TBA salts in DMSO-d6 
(AcO-, Cl-, F-, PO4
3- and SO4
2-). Changes in the appearance of a sample of 88 (2.5 × 
10-3 M) upon the addition 20 equivalents of anions as TBA salts in DMSO-d6 ( AcO
-, 
Cl-, F-, PO4
3- and SO4
2-). (c) With the naked eye and (d) Under UV illumination. 
 
(b) 
(c) 
(d) 
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85
 
 
 
 
2A 107: (a): Structure of 85 showing the NH proton as Ha. (b): Changes in the 1H 
NMR spectrum (Ha proton) of 85 (2.5 × 10-3 M) upon the addition 0 - 20 eqvivalents 
of anions as TBA chloride in DMSO-d6. 
 
 
(a) 
(b) 
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2A 108: (a):  Bind fit graph of the chemical shift of Ha proton (ppm) of 85 (2.5 × 10-3 
M, DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6 (0 - 70 eqs).  (b): 
Speciation graph of the chemical shift of Ha proton (ppm) of 85 (2.5 × 10-3 M, 
DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6. 
 
(a) 
(b) 
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2A 109: (a): Structure of 86 showing the NH proton as Ha. (b): Changes in the 1H 
NMR spectrum (Ha proton) of 86 (2.5 × 10-3 M) upon the addition 0 - 20 eqvivalents 
of anions as TBA chloride in DMSO-d6. 
 
 
(a) 
(b) 
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2A 110: (a): Bind fit graph of the chemical shift of Ha proton (ppm) of 86 (2.5 × 10-3 
M, DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6 (0 - 70 eqs).  (b): 
Speciation graph of the chemical shift of Ha proton (ppm) of 86 (2.5 × 10-3 M, 
DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6. 
 
(b) 
(a) 
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2A 111: (a): Structure of 87 showing the NH proton as Ha. (b): Changes in the 1H 
NMR spectrum (Ha proton) of 87 (2.5 × 10-3 M) upon the addition 0 - 20 eqvivalents 
of anions as TBA chloride in DMSO-d6. 
 
 
(b) 
(a) 
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2A 112: (a): Bind fit graph of the chemical shift of Ha proton (ppm) of 87 (2.5 × 10-3 
M, DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6 (0 - 70 eqs).  (b): 
Speciation graph of the chemical shift of Ha proton (ppm) of 87 (2.5 × 10-3 M, 
DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6. 
 
(b) 
(a) 
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2A 113: (a): Structure of 88 showing the NH proton as Ha. (b): Changes in the 1H 
NMR spectrum (Ha proton) of 88 (2.5 × 10-3 M) upon the addition 0 - 20 eqvivalents 
of anions as TBA chloride in DMSO-d6. 
 
 
 
(a) 
(b) 
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2A 114: (a): Bind fit graph of the chemical shift of Ha proton (ppm) of 88 (2.5 × 10-3 
M, DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6 (0 - 70 eqs).  (b): 
Speciation graph of the chemical shift of Ha proton (ppm) of 88 (2.5 × 10-3 M, 
DMSO-d6)  with increasing TBA chloride equivalents in DMSO-d6. 
 
(b) 
(a) 
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2A 115: (a):  Combination of bind fit graph of the 1H NMR spectrum (chemical shift 
of Ha proton (ppm)) of 85, 86, 87 and 88 (2.5 × 10-3 M, DMSO-d6) with increasing 
TBA chloride equivalents in DMSO-d6. 
2A 116: Scanning electron microscopy (SEM) images  of compound  85 spotted with 
Au, (A): Mag x 100; (B): Mag x 200; (C): Mag x 1000; (D): Mag x 4000; (E): Mag x 
7000. 
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2A 117: Scanning electron microscopy (SEM) images  of compound  86 spotted with 
Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 1000; (D): Mag x 1800; (E): Mag x 
4000; (F): Mag x 7000. 
 
2A 118: Scanning electron microscopy (SEM) images  of compound  87 spotted with 
Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 500; (D): Mag x 1000; (E): Mag x 
4000; (F): Mag x 7000. 
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2A 119: Scanning electron microscopy (SEM) images  of compound  88 spotted with 
Au, (A): Mag x 100; (B): Mag x 250; (C): Mag x 1000; (D): Mag x 4000; (E): Mag x 
7000. 
 
 
 
 
 
 
 
 
 
 
 
 
214 
 
Appendix 4: 
 
4A 1: The 1H NMR spectrum of 122 (500.13 MHz, DMSO-d6) 
 
 
4A 2: The 13C NMR spectrum of 122 (125.76 MHz, DMSO-d6) 
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4A 3: The 1H NMR spectrum 132 (500.13 MHz, DMSO-d6) 
 
 
4A 4: The 1H NMR spectrum of 135 (500.13 MHz, DMSO-d6) 
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4A 5: The 13C NMR spectrum of 135 (125.76 MHz, DMSO-d6) 
 
 
4A 6: The 1H NMR spectrum of 136 (500.13 MHz, DMSO-d6) 
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4A 7: The 1H NMR spectrum of 119 (500.13 MHz, DMSO-d6) 
 
 
4A 8: The 13C NMR spectrum of 119 (125.76 MHz, DMSO-d6) 
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4A 9: The 1H NMR spectrum of 120 (500.13 MHz, CDCl3) 
 
 
4A 10: The 13C NMR spectrum of 120 (125.76 MHz, CDCl3) 
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4A 11: The 1H NMR spectrum of 123 (500.13 MHz, CDCl3) 
 
 
4A 12: The 13C NMR spectrum of 123 (125.76 MHz, CDCl3) 
220 
 
 
4A 13: The 1H NMR spectrum of 137 (500.13 MHz, DMSO-d6) 
 
 
4A 14: The 13C NMR spectrum of 137 (125.76 MHz, DMSO-d6) 
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4A 15: The 1H NMR spectrum of 138 (500.13 MHz, DMSO-d6) 
 
 
4A 16: The 13C NMR spectrum of 138 (125.76 MHz, DMSO-d6) 
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4A 17: The 1H NMR spectrum of 139 (500.13 MHz, DMSO-d6) 
 
 
4A 18: The 13C NMR spectrum of 139 (125.76 MHz, DMSO-d6) 
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4A 19: The 1H NMR spectrum of 140 (500.13 MHz, DMSO-d6) 
 
 
4A 20: The 13C NMR spectrum of 140 (125.76 MHz, DMSO-d6) 
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4A 21: The 1H NMR spectrum of 141 (500.13 MHz, DMSO-d6) 
 
 
4A 22: The 13C NMR spectrum of 141 (125.76 MHz, DMSO-d6) 
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4A 23: The 1H NMR spectrum of 124 (500.13 MHz, CDCl3) 
 
 
4A 24: The 13C NMR spectrum of 124 (125.76 MHz, CDCl3) 
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4A 25: The 1H NMR spectrum of 142 (500.13 MHz, DMSO-d6) 
 
 
4A 26: The 13C NMR spectrum of 142 (125.76 MHz, DMSO-d6) 
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4A 27: The 1H NMR spectrum of 143 (500.13 MHz, DMSO-d6) 
 
 
4A 28: The 13C NMR spectrum of 143 (125.76 MHz, DMSO-d6) 
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4A 29: The 1H NMR spectrum of 144 (500 .13 MHz, DMSO-d6) 
 
 
4A 30: The 13C NMR spectrum of 144 (125.76 MHz, DMSO-d6) 
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4A 31: The 1H NMR spectrum of 145 (500.13 MHz, DMSO-d6) 
 
 
4A 32: The COSY spectrum of the aliphatic region of 145 (125.76 MHz, DMSO-d6) 
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4A 33: The 13C NMR spectrum of 145 (125.76 MHz, DMSO-d6)  
 
 
4A 34: The 1H NMR spectrum of 146 (500.13 MHz, DMSO-d6) 
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4A 35: The COSY spectrum of the aliphatic region of 146 (125.76 MHz, DMSO-d6) 
 
 
4A 36: The 13C NMR spectrum of 146 (125.76 MHz, DMSO-d6) 
 
232 
 
 
4A 37: The 1H NMR spectrum of 147 (500.13 MHz, DMSO-d6) 
 
 
4A 38: The COSY spectrum of the aliphatic region of 147 (125.76 MHz, DMSO-d6) 
 
 
233 
 
 
4A 39: The 13C NMR spectrum of 147 (125.76 MHz, DMSO-d6) 
 
 
4A 40: The 1H NMR spectrum of 148 (500.13 MHz, DMSO-d6) 
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4A 41: The COSY spectrum of the aliphatic region of 148 (125.76 MHz, DMSO-d6) 
 
 
4A 42: The 13C NMR spectrum of 148 (125.76 MHz, DMSO-d6) 
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4A 43: Representative photographs of up-side down vials containing LMWOGs 
prepared via heating-ultrasound (H-C) and heating-cooling (H-U). (A) Gelator 105 in 
DMSO. (B) Gelator 106 in DMF. (C) Gelator 113 in EtOH (left) and in toluene (right). 
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